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ABSTRACT 
A dissertation submi tted in partial ful f i l lment o f  the 
requirements for the degree o f  doctor of phi losophy. 
by Kevin R. McCormick 
Medical college of Virginia 
Virginia Commonwealth University 
Advisor: Jack L. Haar 
The suppression of the immune response i n senescent 
animals, including humans, is not complete and may be 
ameliorated by spe cif i c  interve ntions . Previous studies 
have suggested that the replacement of thymus factors lost 
with age may rejuvenate s enescent immune function . 
Simi larly, exogenous growth hormone has been reported to 
improve senescent immune function in certain mammals. Other 
studies with the immunomodulator PSK claim to restore 
tumor-induced immunosuppression even in aged mice. This 
proje ct investigated the abilities of thymus supernatant, 
ovi ne growth hormone, and PSK to rejuvenate different 
parameters of the senescent immune response. 
In the first series of experiments, erythroid depleted bone 
marrow cells from 3 month and 24 mo nth old CBA (Thy 1.2) 
mice were given to irradiated AKR (Thyl.1) mice and allowed 
to repopulate for 30 days. Flow cytometry analysis using 
mAb Thy 1 . 1  and Thy 1.2 revealed that the old bone marrow 
was deficient in its ability to repopulate the thymus. 
Subsequent experiments revealed that treatment of the old 
bone marrow with thymus supernatant, made from neonatal 
thymus cultures, could restore the thymus repopulating 
ability of these cells. 
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The second part of this project investigated the reported 
ability of growth hormone to rejuvenate the age-involuted 
thymus and senescent immune response. Limited success was 
achieved using subcutaneous timed-release pellets 
containing ovine growth hormone. Twenty-four month old 
mice treated in this manner f or 8 weeks demonstrated larger 
thymuses with nearly normal thymus morphology, i.e. 
distinct cortical and medull ary regions. Various assays of 
cellular immune function exhibited no improvement. 
PSK injections every other day injections of 18 month old 
mice, for one month, resulted in an increa se in spleni c 
mass when compared to saline treated age-matched controls. 
There was no improvem ent in the thymus morphology or in the 
cellular immune function of the treated animals. 
GENERAL INTRODUCTION 
This dissertation examines the function of the senescent 
thymus in mice as it relates to bone marrow stem cells and 
cellular immun e functi on. These systems are significantly 
impaired with age and result in serious health problems in 
elderly individuals. Motivated by the possible health-care 
benefits for a rapidly ag in g society and a desire to 
understand basic princ iples o f  immune sy stem ontogeny, 
numerous invest igators have turned thei r  attention to  thi s  
top ic over the. l ast two decades . What fol lows i s  a br i e f  
desc ription of normal thymus status and senescence related 
changes. Spec if ic background rel ated to the experiments o f  
this dissertation i s  g iven i n  the in troduc tions to each of 
the chapters . 
Normal Thymus Morphology 
The thymus is a primary lympho id organ that is  l ocated j us t  
posterior t o  the sternum , s l ightly superior to the heart 
and anterior to the aorta and superior vena cava in  the 
anterior mediastinum. Embryol ogically the thymus i s  derived 
from the epithel ium of the th ird and the ventral port i on o f  
the fourth pharyngea l  pouches . I t  i s  a b i l obed structure 
that is  flattened in its anterior-posterior aspect . Each 
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l obe is  incompletely d iv ided into lobules by connect ive 
t i s sue septae whi ch proj ect inward from the th in capsu l e  o f  
the lobes . wi thin each l obule , the thymus is  d ivided into 
a cortex and medul l a . The cort ical area i s  densely 
popul ated with immature or devel oping lymphocytes and for 
thi s  reason i s  dark sta ining in rout ine H&E h istol ogical 
preparations . The l e s s  densely packed medul l a  i s  l ighte r  
sta in ing and the thymic ep ithel ial cel l s  a r e  clearly 
d i st i ngu ishabl e .  The medul l a  also  conta ins concentr i c  
whorl s of ep ithe l i a l  cel l s  that sometimes contain 
keratohyal in granules . These structures are cal l ed 
Has s a l l ' s  or thymi c  corpuscles. The thymus has e f ferent 
lymphat ics which dra in the organ but there are no a f ferent 
lymphatics , thus there i s  no lymphatic dra inage through the 
thymus . Blood i s  suppl ied to the thymus by cap i l l aries  o f  
the inferior thyroid and interna l thoracic arteries . Thes e  
cap i l laries enter the cortex and form anastomos ing arcades 
a l ong the cort ico-medul lary border . Bl ood dra ins via 
medullary venules i nto internal thorac ic , inferior thyro i d , 
and left brachiocephal ic veins . 
Normal Thymus Function 
I n  order to understand the role o f  the thymus in  norma l 
immune funct ion one must understand the ontogeny o f  
lymphopo ies is . Three populations o f  cel l s  repres ent the 
maj or cell types in this process . The first is  
multipotentia l hematopoietic stem cel l s. These first 
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develop in the blood islands of the yolk sac from 
mesenchymal cells (Moore and Metcalf, 1970; Haar and 
Ackerman, 1971). Hematopoietic stem cells from the yolk 
sac seed the fetal liver. The fetal liver in turn seeds 
the spleen and the bone marrow with stem cells. After 
birth, red bone marrow is the chief site of hematopoiesis. 
Each of these sites has a pool of self-renewing multipotent 
or pluripotent stem cells capable of differentiating into 
all of the mature functional blood cells (Abramson et al., 
1977; Suda et al., 1983). The second population of 
hematopoietic cells is composed of several types of 
differentiating progenitor cells. These cells have a 
strong, but probably limited, ability to renew themselves 
and exhibit varying degrees of commitment to specific 
lineages (Abramson et al., 1977; Wendling et al., 1985). 
The pro thymocyte or pre-thymic stem cell is an example of 
one of these cell types. These yet to be isolated cells 
have differentiated from pluripotent stem cells and are 
developmentally committed to becoming thymocytes. The 
third population of hematopoietic cells is represented by 
the fully functional mature blood cells (Cormack, 1987). 
Researchers attempting to isolate pluripotent stem cells 
have done so by seeking cell markers that are unique to 
this first population of hematopoietic cells. Monoclonal 
antibodies (mAbs) have been a major tool in these studies. 
Two such mAbs are Sca-1 and Sca-2 (stem cell antigens 1 and 
2 ) . spangrude et al. (1988a) reported that Sca-1+ bone 
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marrow cells with the following characteristics are 
pluripotent hematopoietic stem cells: l.expression of low 
but significant levels of cell differentiation antigen Thy-
1 (ThY-l�l; 2.are negative for cell surface markers 
characteristic of B cells, granulocytes, and myelomonocytic 
cell lineages (Lin-I. These sca-l+, ThY-l�' and Lin- cells 
represent the first population of hematopoietic cells, 
pluripotent stem cells. Sca-l antigen is expressed 
throughout T cell development, including mature peripheral 
T cells and is identical to the previously known Ly-6A.2 
molecule. Sca-2 is lost during maturation and is therefore 
only found on immature thymocytes. In addition, Sca-2 is 
expressed on germinal center B cells ( Spangrude et al., 
1 9 8 8b ) . 
Attempts to isolate the second population of hematopoietic 
cells, committed precursor cells, have also used cell 
markers that are specific for a given lineage. One such 
marker of differentiated stem cells is terminal 
deoxynucleotidyl transferase ( TdT) . TdT is an 
intracellular enzyme which marks the initial 
differentiation of the pluripotent stem cells of the yolk 
sac, bone marrow, and liver into lymphocyte precursors. 
TdT is also found on cortical, Thy 1+, thymocytes. TdT is 
lost during intrathymic maturation and is not found in the 
medullary T cell populations or in peripheral lymphoid 
organs (Bollum, 1 9 7 5; Goldschneider et al., 1977). TdT+ 
bone marrow cells represent the second group of 
hematopoietic cells, committed but und i f ferent iated 
progenitors . As such, TdT represents the earl iest marker 
for stem cel l s  committed to the lymphocyte l ineage . 
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Lymphopo ies i s  begins at 1 1 - 14 days o f  gestat ion in the 
mouse , 8 to 9 weeks in humans, when prothymocytes colon i z e  
the thymus . At thi s  stage o f  devel opment , the l iver i s  the 
s ite of prol i feration and early d i f ferent iat ion o f  
pluripotent hematopoietic stem cel l s . At day 1 3  the 
earl iest known thymocyte (T cell ) surface ant igen , Thy 1 
(CD2 in man ) , i s  exp ressed on the lympho id cell s wh ich 
have seeded the thymus . Thy 1 is the earl iest intrathym i c  
T cel l  marker , while ontogenet ica l ly TdT is  a marker for 
stem cel ls committed to lymphocyte l ineages and Sca-1 is 
found on pluripotent stem cells . 
The thymus is necessary for the development o f  norma l 
immune function (Mil ler , 1 9 6 1 ; Stutman , 1 9 7 7 ) . Bone marrow 
derived T cel l  progenitors mature in the thymus , a proces s  
commonly re ferred t o  a s  " thymic education" . Whi le the 
maturation of T-Iymphocytes is known to take place in the 
thymus , the exact mechan i sm of this  " education"  is unknown . 
Current theories o f  T cel l  maturation state that pos itive 
and negative selection events occur in the thymus ( von 
Boehmer et al . ,  1 9 8 9 ) . The overwhelming maj ority o f  thymus 
immigrants do not survive this sel ect ion proces s  and d ie 
intrathymical ly .  Negative selection involves the remova l 
of all  cel ls that react too wel l  ( i . e . as  i f  fore ign ) with 
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sel f -MHC . Negat ive selection i s  the mechanism by which 
tol e rance to sel f antigens is  induced . Kappler et a l . 
(1987) have shown that T cel l s  which react with MHC c l a s s  
I I  prote ins are depleted dur ing intrathymic maturat ion and 
are there fore el iminated from the mature thymocyte and 
peripheral T cel l populations . pos it ive select ion i s  the 
maturat ion of the cel ls that recogn i z e  fore ign antigen i n  
assoc iat ion with sel f-MHC . A recent study ( Marrack et a l . ,  
1989) indicates that pos it ive select ion may occur through 
cel l -cel l  contact with a unique form o f  MHC present on 
thymic ep ithel ial cel l s . Thymi c  nurse ce l l s , wh ich 
comp l etely enclose devel oping thymocytes, are also be l i eved 
to p l ay a role in the selection process , although what that 
rol e  is has yet to be determined ( Kyewski , 1986). The 
relationship between these thymi c  ep ithe l i a l  cel l s  and 
devel op ing thymocytes is unique and may provide a crit i c a l  
microenv ironment f o r  T cel l devel opment . 
Recent work on the ontogeny o f  the T cel l receptor (TC R) 
has shed some l ight on what happens genetically to the 
devel op ing thymocyte in the thymus but what role the 
var i ous cel l types play and how the select ion occurs 
rema ins unclear . The T cel l receptor is composed o f  one o f  
two heterodimeric proteins , either as o r  TO. The TO T CR 
appears first ontogenetical ly but decreases with the 
approach of birth and only accounts for 1 - 1 0 %  of the 
peripheral blood T cel ls  in man and mouse . TCR as i s  the 
form found on most mature T cel l s . Studies o f  TCR 
deve l opment indicate that the thymus is the principal s ite 
of  the gene rearrangements respons ible for the ant igen 
recognit ion and sel f-tolerance of the mature TCR (revi ew: 
Strominger, 1 9 8 9 ) . s t i l l , the relationship between thes e  
events and the various constituents which compose the 
thymic microenv ironment rema ins uneluc idated . 
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The general pattern o f  devel opment is as fol l ows . T c e l l  
progen itors leave the bone marrow o r  fetal l iver and 
migrate through the b l ood to the thymus . The cel l s  l e ave 
the bl ood stream and enter the subcapsul ar space of the 
thymus . E ighty- f ive to n inety percent o f  the thymus 
lymphocytes are l ocated in the cortex . In addition , it i s  
i n  the cortex o f  the thymus that the maj ority o f  
intrathymic pro l i ferat i on takes place . Cort ical thymocytes 
are sens itive to cort i s one and the abi l ity to surv ive 
cort i sone treatment is o ften used to dist inguish between 
mature and immature thymocytes . The maturing T ce l l  is  
bel ieved to move progre s s ively into the cortex and 
eventual ly into the medul l a  of the thymus be fore it i s  
exported t o  the peripheral lymphoid organs . There i s  
confl icting evidence as t o  the status o f  recent thymus 
emigrants . S ome report that the T cel l is  ful ly mature when 
it leaves the thymus , whi l e  others claim that there i s  
post-thymic maturat ion i n  secondary lymphoid organs 
( Stutman , 1 9 7 8 ; piquet et al . ,  1 9 8 1 ; Scol l ay , 1 9 8 2 ) . The 
weight of evidence favors the view that recent thymus 
emigrants are ful l y  mature T cel l s  from the medul l a  o f  the 
thymus ( Scol l ay et al . ,  1984; Shortman et a l . ,  1987). 
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Humoral factors derived from thymic epithe l i a l  cel l s  are 
bel ieved to be i nvolved in the maturation of T cel l s  and 
the ma intenance of cel lular immunity but the i r  exact rol e  
is  unclear . There are three recogn i z ed and rel atively we l l  
characteri z ed thymic hormones : thymo s i n , thymopo i et in , and 
thymu l i n  ( origina l ly cal led facteur thymic serique , FTS ) . 
These and other more crude preparati ons have been reported 
to promote the d i f ferentiation of T cel l s  a s  indicated by 
ce l l  surface ant igens ( Good , 1983; S tutman , 1983). 
However , due to c ontradictory findings with varying doses 
and the ab i l ity of non-thymus factors to mimic some o f  
these e f fects the role o f  thymic humoral factors i s  st i l l  
unclear ( Stutman , 1983). Whi l e  these humora l factors have 
been shown to be suffic ient for alteration o f  T cel l 
phenotype , the ab i l ity o f  non-thymus p roducts to mimic 
these e f fects has compl icated the exp l anation of the i r  rol e  
i n  T cell  maturat ion and d i f ferentiation . s tutman ( 1983) 
ma intains that cAMP changes induced by thymic hormones i s  
the necessary event i n  T cel l maturation . 
other experiments have suggested that the precursors need 
to come in contact with thymic ep ithel ial ce l l s  in order to 
become ful ly functional ( Potworoski et al . ,  1 9 8 6 ; 
LaRoce l l e  and Jones , 1 9 8 9 ) . As discussed above , the exact 
mechan isms of T cell d i fferentiation are uncl ear but the 
thymic microenvironment appears t o be cri t ical for the 
p ro du ction of mature funct i ona l T cells. According to 
stutman's model o f  T c el l differentiation ( stutman, 1 9 8 3 ) , 
th e necessary components o f  the thymic microenvironment 
needed for the production o f  mature and functional T cel l s  
are the thymic humoral factors , thymic stromal cells, and 
pos s ib ly the res ident mature T cells of the thymus. 
Thymus Morphology In Senescence 
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The first manifestation o f  the senescence of the immune 
system, thymic involution, was known to anatomist centuries 
before an even rUdimentary understanding of immune function 
was obtained. In thi s  century , nearly three decades be fore 
the rol e  o f  the thymus in lymphocyte maturat ion would b e  
eluc idated , Boyd ( 19 3 2 ) pub l i shed his  paper on the weight 
o f  the thymus in health and d i sease . Boyd noted that the 
overal l  s i z e  of  the human thymus was decreased with 
advan c i ng age and that connect ive t issue , part icul arly 
adipose tissue , composed 9 0 %  o f  the organ a fter 40  years o f  
age . Th e th ymic cortex , which accounted for 4 5% o f  the 
thymi c  mass during ch i l dhood and adol escence , was reduced 
to 7 - 8 %  o f  the total mass . The medul la , wh ich had 
accounted for over 2 0 % of the original mass , only compr i s ed 
2 - 3 %  o f  the thymus a fter the age o f  forty . 
Textbo oks and even j ournal art icles descr ib ing thymus 
morphol ogy are repl ete with references to a puberty 
in i t i ated involut ion ( Cormack , 1987; We iss , 1 9 8 3 ;  
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Graudecker , 197 8 ; s ztein and A .  Goldste in , 198 6 ; Frasca et 
a l . ,  198 2 ) .  Yet examinat ion o f  human thymus from sudden 
death autopsies reveals steady rate of involut ion beg i nn i ng 
at one year o f  age ( Ste inmann et a l . ,  1 9 8 5 ) . Others have 
described thymus s i z e , we ight and degree of involut i on as 
so var iable as to make mean values by age worthless  ( S l oa n , 
194 3 ; Kenda l l  et a l . ,  1 9 8 0 ) . S l oan ( 1 9 4 3 )  g ives l engthy 
descript ions of the thymuses he examined . H i s  descr ipt ions 
are o f  a gradua l inf i ltrat ion o f  fat between thymus 
l obules such that in many older individual s  the thym i c  
ep ithel ium is  reduced t o  thin plates sandwiched between 
fatty connect ive t issue . Gaudecker ( 197 8 )  a l s o  describes 
the thymus o f  an  older person as " is lands " o f  thymus t i s sue 
with in adipose t i s sue and adds that these i s l ands are no 
di f ferent than that of  a chi ld . A more recent revi ew o f  
human thymic involut ion ( Kra ft et al . ,  198 8 )  has rea f f i rmed 
these f indings . Kra ft et al . re ferred to the o rgan a s  the 
"thymic fat body" and described the involution as a 
" terminal d isorgani z at i on "  o f  the ent ire organ i n  wh ich the 
lobul ar structure is lost and the result ing thin b ranch ing 
system o f  epithel ial plates l ack Hassal l ' s  corpuscl e s . The 
above descript ions are further developed in a report by 
steinmann et a l . ( 19 8 5 )  which describes extens ive ad ipose 
replacement o f  connective tissue and perivascu l a r  space . 
The i r  report also supports a puberty- independent thym i c  
involut ion . 
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Regardless o f  whether thymic involut ion i s  i n i t i ated by the 
hormona l events of  puberty , it is  clear that stero id 
compounds have a s ign i ficant and deleter i ous e f fect on the 
thymus and cel lular immune funct ion ( Cl aman , 1 9 7 2 ; Arya et 
a l . ,  1 9 8 4 ) . It  is also  c l ear that the thymus does undergo 
an involut i on with age that includes extens ive inf i ltrat ion 
o f  adipose tissue into the organ . The rate and extent o f  
th is  invo lut ion i s  h ighly variable and i s  a f fected by many 
factors including di sease states ( Boyd , 1 9 3 2; S l oan , 19 4 3 ; 
Kendal l  et a l . ,  1 9 8 0 ) . 
S enescent Thymus Function 
Contrary to traditional cl inical thought , the thymus does 
cont inue to funct ion throughout adult l i fe ( Kenda l l , 1 9 8 4 ) . T  
cel l precursors cont inue to enter the thymus from the bone 
marrow and d i f ferent iate into phenotyp ical ly mature T c el l s  
throughout adult l i fe ( ste inmann and Mul l er-Herme l i nk ,  
1 9 8 4 ) . However , the senescent thymus funct ions at a 
greatly reduced l evel , re flecting its morphological state . 
The product i on o f  thymus factors is  decreased in l ater l i fe 
( Bach et al . ,  1 9 7 5a , b ;  Lewis et al . ,  1 9 7 8 ; Oosterom and 
Kater, 1 9 8 1 ; Gof f  et al . ,  1 9 8 7 ) . The decrease i n  at l east 
some thymic hormones may be due in part to inh i b i t i ng 
factors in the blood ( Bach and Beaura in , 1 9 7 9 ) . Thymus 
factors have been postulated to act both intrathymical ly , 
as discussed above , and peripherally ,  including the bone 
marrow . The loss of thymic hormones with age has been 
hypothes i z ed to be a contribut ing factor to the overa l l  
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senescence of the immune system ( Kruisbeek, 1 9 8 1 ) . I n  
add i t ion , the numbe r  o f  T cel l s  leaving the thymus i s  
b el ieved t o  decrease with age . This  is  supported by the 
observation that thymuses from old mice have a decre a s ed 
ab i l ity to repopul ate the T cel l dependent areas o f  l ymph 
nodes ( H irokawa and Maki nodan , 1 9 7 5 ) . The decrease i n  
thymus function with age may very wel l  b e  the primary event 
in the senescence of the immune system . 
Senescent Immune Function 
The decl ine in immune functi on with aging i s  widel y  known 
and we l l  documented ( reviews : Cinader, 19 8 2 ; Doggett et 
a l . ,  1981; Jones and Enni st , 1 9 8 5 ; S z ewczuk and Wade , 1983; 
Wal ford, 19 8 0 ; W eks l er , 1 9 8 2 , 1 9 8 3 ) . This dec l ine i n  
immunocompetence i s  p r imarily the result of de f i c i enc i e s  i n  
cel lular immune function . Decl ines in humoral immunity a re 
only s l ight and most l ikely due to dys funct ion of  
regu l atory T cel l s . 
The changes in humoral immun ity with age are sl ight and 
generally do not contribute greatly to the cl inica l ly 
expressed pathologies o f  immunosenescence . Total 
immunoglobul in titers do not change s igni ficantly with age, 
a lthough the distribution of d i fferent classes does change . 
IgA and IgG concentrations are increased , whi l e  IgM 
concentration is decreased ( Hal lgren et al . ,  1 9 7 3 ) . 
Paradoxical ly , ant ibody to foreign ant igens decreases with 
advanced age ( Roberts-Thomson et al . ,  197 4 ) , whil e auto-
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ant ibodies increase ( Axel sson et al . ,  1 9 6 6 ; Rowl ey et a l . ,  
1 968 ) . In sp ite o f  the increased incidence o f  auto­
ant ibodies , there is no increase in the inc idence o f  
auto immunity with age . There is a s ign i f icant increase i n  
the inc idence o f  benign monoclonal gammopath ies i n  l ater 
l i fe ( Axelson, 1 9 6 6 ) . This  dysregulation of humoral 
immun ity appears to be thymus rel ated s ince neonatal 
thymectomy results in an earl ier onset and an increased 
inc idence o f  monocl onal immunoglobul ins ( Radl et a l . ,  
1 9 8 0 )  . 
The changes in cellular immune function with age are much 
more pro found than those o f  the humoral component . Studies 
o f  cel lular immunosenescence in humans have reported that 
the total number of T cel l s  is decreased with age ( Lighart 
et al . , 19 8 5 ; Nagel et al . , 19 8 1 ; O ' Leary et a l . , 1 9 8 3 ) . Other 
studies in humans have found no decrease or an 
ins ign i f icant decrease in the absolute number of per ipheral 
T cel l s  ( Cowan et a l . ,  1 9 8 1 ; Nagel et al . ,  1 9 8 1 ;  Kru i sbeek , 
1 9 8 1 ) . These discrepancies may be a product o f  the assays 
used . Early studies used the sheep erythrocyte rosette 
forming assay whi l e  more recent studies have uti l i z ed 
monocl onal ant ibody l abel l ing techniques . I t  should a l s o  
be rea l i z ed that total numbers of T cel l s  may exh ib it great 
variab il ity among ind ividual s  and may not re fl ect 
immunological status . More important than cel l numbers i s  
the funct iona l status of the cel l s . The funct ional state i s  
greatly reduced as determined i n  numerous assay systems 
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wh i ch use equal numbers o f  cells from young and aged 
subjects ,  thereby controlling for any d i fferences in cell 
numbers ( see reviews above ) . Studies i n  mice have found 
that the changes in T cel l  number vary according to the 
t i ssue source but in general are unchanged with age 
( Makinodan et al . , 19 8 6 ) . There i s  however ,  a s ign i f i cant 
decrease with age in the percentage of T cells that respond 
to ant igenic challenge ( Cowan et al . , 1 9 8 1 )  and an overall 
decrease in nearly all T cel l  funct ions . 
various assay systems have been devi sed to assess normal 
cellular immune function . The immune system of aged humans 
and l aboratory anima l s  are seriously impa ired as mea sured 
by assays of T cell function . The results o f  these assays 
re flect the increased incidence of di sease , part icularly 
in fect i ous diseases and cancer , seen in the elderly 
populat ion . T cells have a decrease i n  the i r  response t o  
plant lect ins , both Con A ( Hi rokawa and Makinodan , 1 9 7 5 ; 
G ill i s  et al . , 1 9 8 1 ; Thoman and We igle , 1 9 8 1  & 1 9 8 2 ) and 
PHA ( Cowan et al . ,  19 8 1 ;  G ill i s  et a l . , 1 9 8 1 ;  Mys l iwska et 
a l . ,  1 9 8 5 )  . T cel l populat ions from aged donors a l s o  have 
a decreased level of I L-2  production and I L- 2  receptors 
(Chang et a l . ,  1 9 8 2 ; G ill i s  et al . , 19 8 1 ; G i lman et a l . ,  
1 9 8 2 ; Mi l ler and Stutman , 19 8 1 ; Thoman et a l . ,  1 9 8 1 ; 
Thoman and We igl e , 1 9 8 2 ) . The fai lure o f  the I L- 2  system 
is one o f  the critical failures in the s enescent immune 
response s ince I L-2  is necessary for the prol iferat ion of 
act ivated lymphocytes . cytotoxic T-Iymphocytes ( CTLs ) a re 
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responsible for immune survei l lance and elimination o f  
v i ra l ly infected and neop l astic cel l s . CTL activity is 
greatly decreased with age ( Becker et a l . , 1979 ; Haa r  et 
a l . , 198 8 )  and corresponds to the increased incidence o f  
cancer and serious viral i l l nesses among the elderly. The 
rejection of  fore ign t i s sue gra fts i s  another examp l e  o f  
the body's immune system f ighting fore ign invasion . The 
a l l oant ibody response of aged anima l s  i s  a l so great l y  
reduced with age ( Makinodan e t  al . ,  1 9 7 6 ) . Another 
genera l ized exampl e  of a v igorous immune respons e  i s  
de layed-type hypersens itivity ( DTH ) . DTH i s  diminished i n  
e l derly individual s  and exh ib its a n  inexplicably h igh 
correlation with mortal ity ( Roberts-Thomson et a l . ,  1 9 7 4 ) . 
Interventions in the Aqi nq Proce s s  
The suppress ion o f  the immune response with age i s  not 
comp l ete and exhibits some revers ibi l ity , at least under 
certa in experimental conditions . These attempts at 
immunological rej uvenat ion general ly fal l into one o f  
three categories : 1 .  Attempts to replace phys i o l og i c a l ly 
act ive factors which are lost or diminished with age; 
2 .  Pharmacological treatments; and 3 .  Nutrit i onal 
man ipulations . Limited success in boosting immune response 
has been achieved with each of these forms of treatment . 
s t i l l  no last ing and cl inica l ly appl icab l e  treatment has 
been found . 
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Attempts to rej uvenate the senescent immune response by 
rep lac ing thymus tissue and/or thymus-derived factors have 
been numerous and variably succe s s ful . Bach (19 7 7 ) found 
that thymic factor could prevent the depres s ion o f  
lymphocyte cytotoxic ity i n  adult thymectomi z ed mice but 
depressed the cytotoxic response in young and aged mice 
( Bach , 19 7 7 ) . I n  one study ( Cowan et a l . , 1 9 81 ) , thymo s i n  
fract ion 5 i n  v itro was found t o  increas e  the mixed 
lymphocyte reacti on of human peripheral b l ood lymphocytes . 
However , other studies found no improvement in the immune 
response of peripheral blood lymphocytes of elderly human 
subj ects (Qu inti et al . ,  19 8 1 ; Ershler et a l . ,  1 9 85 ) . 
Frasca et al . ( 19 8 2 ) found that inj ect i on s  o f  synthet i c  
thymos in-al in aged mice increased helper cel l act iv ity a s  
measured b y  ant i -TNP antibody producti on a n d  T cel l 
pro l i feration . Two later studies ( Frasca et a l . ,  1 9 8 6 ; 
Frasca et al . ,  1 9 8 7 )  found that it was the N-terminal ha l f  
o f  thymos in-a1 (N14 fragment ) which was respons ibl e  for the 
augmented immune response in aged mice . These later 
studies a l so found that the N14 fragment was respons ible  
for  increas ing the frequency o f  mitogen respons ive cel l s  i n  
the spl eens o f  old but not young mice . 
The mechan i sm by which thymic factors may s t imulate the 
senescent immune response rema ins to be eluc idated but it 
is  an encouraging l ine of inquiry . A recently repo rted 
cl inical study ( Ershler et al . ,  1 9 8 9 ) i nd icates that 
thymo s in-a1  may act as an e f fect ive adj uvant for 
prophyl actic vaccinat ions in the elderly . 
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other researchers have attempted to rejuvenate the 
senescent immune response through man ipulations of  the 
endocr ine system . Fabris  et ale ( 19 8 6 )  examined the 
immuno l og ica l ef fects o f  a spec i f ic d ietary supplement 
known to act on the endocrine system . I t  is  known that 
lysine is essential for body growth and that arginine can 
augment the secret ion of  growth hormone . Fabris and 
col l eagues treated aged mice with a commerc ial ly ava i l ab l e  
lys ine-arginine supplement ( Neoi odoars o l oR) for f i fteen 
days . Their results indicate a restorat ion o f  thymi c  
production of thymul in and a n  increased respons ivenes s  o f  
sp l een cel l s  to PHA. Con A ,  LPS , and natura l k i l l e r  c e l l 
responses were unchanged . Level s  o f  c i rculat ing thymul in 
in aged human subjects were found to be increased a fter 3 0 -
4 0  days o f  treatment . It  was noted that there was no 
d i rect e ffect of the lys ine-arg in ine on spleen cel l s  in 
v itro . This lack of direct e ffect on spl enocytes ind icates 
that the improvement is  probably due to  thymic or other 
endocrine changes . 
Recently two groups of investigators have attempted to 
restore immune function in senescent anima l s  us ing anterior 
p itu itary hormones ( Go f f  et  al . ,  1 9 8 7 ; Roth et  al . ,  1 9 8 4 ; 
Kel ley et al . ,  19 8 6 ) . These studies in rats and dogs 
ind icate that pituitary hormones may be able to improve the 
senescent immune response . This  work may contribute 
s ign i f icantly to our understand ing of the interact i ons o f  
the neuroendocrine and immune systems i n  aging and other 
l i fe events . The des ign and results o f  these studies  are 
rev i ewed in greater detai l  in the introduction to Chapter 
2 .  
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s t i l l  other researchers have attacked the immunosenescent 
state armed with pharmacol ogical agents bel ieved to be 
irnmunopotentiators . Bruley-Rosset et al e ( 19 8 6 )  achieved 
improved immune responses in aged mice us ing a four month 
treatment of  sodium d ithiocarbamate ,  DTC ( ImuthioIR) .  
Treatment with thi s  synthetic agent restored Con A 
response , CTL activity , and serum thymic factor l eve l s . 
PHA response and delayed-type hypersens itivity were a l so 
improved . Natural k i l l er cel l  act ivity and gra ft versus 
host mortal ity were not changed by the treatment . The 
authors bel ieve that the improvement is  due to restorat ion 
of thymus endocrine act ivities . 
Another chemical that has been shown to have 
irnmunopotentiating activity is isoprinos ine . I soprino s ine 
is a chemical immunopotent iator that has been shown to be 
capabl e  of st imulating immune funct ion in cancer pat ients . 
A study with hamsters has shown that isoprinosine i s  
capable o f  restoring certain immunol ogical funct ions t o  
near youthful levels ( Tsang e t  a l . ,  1 9 8 3 ) . They found 
that a s ingle IP inj ection was capable of restoring natura l 
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k i l l e r  cel l  act ivity , suppressor cel l function , and PHA 
response . Furthermore, they found that weekly inject i ons 
ma inta ined these immunol og ical parameters at or near the 
l eve l s  found in young hamsters . The mechanism o f  act i o n  i s  
unknown but the authors specul ate that it may be due to  
increases in interl eukin product ion . 
Caloric restrict ion in aged mice has been shown to imp rove 
the senescent immune response , increase surv ival  time, and 
decrease the incidence of tumors ( Gerbase-Del ima et a l . ,  
1975 ; we indruch et a l . ,  198 2 ; We indruch et al . ,  198 3 ) .  
Whi l e  these studies may help to unravel the mysteries o f  
immunosenescence, the cl inical applications o f  caloric 
restrict ion are obviously l imited . 
Thes e  studies indicate that rej uvenat ion o f  the senescent 
immune response is a promis ing endeavor . The current b ody 
o f  knowl edge is encouraging but the bas ic mechani sms o f  the 
impa i rment and restitution of immune function are sti l l  
unresolved . In addition , the c l inical appl ications o f  
these immunotherapies has yet t o  b e  determined . 
Chapter One 
The Bone Marrow - Thymu s  Axi s in Senescence 
The necess ity of the thymus for the devel opment of normal 
immune funct ion i s  wel l  documented ( Mi l l er , 1 9 6 1 ; s tutman, 
1 9 77) , and its involution with age has l ong been known 
( Boyd, 1 9 3 2 ) . In spite of thi s , a l l  o f  the functions o f  
the thymus are st i l l  not understood including the mechani sm 
o f  thymocyte maturat ion . I t  has been postul ated that the 
thym i c  hormones may act on lymphocyte precursors i n  the 
bone marrow and that the l o s s  of thymic factors dur ing 
senescence may be a contributi ng factor to the decrea s ed 
cel lu l ar immune funct ion ( Krui sbeek , 1 9 8 1 ) . 
There is  a s ignif icant amount o f  exper imental evidence to 
suppo rt the hypothes is  that thymic factors influence T c el l  
p recursors in the bone marrow . Bone marrow from thymus 
deprived mice have a greatly reduced capacity to produce 
colony forming units in the spleen ( CFU-S ) ( Z ipori and 
Tra inin , 1 9 7 3 ; Z ipori and Tra inin , 1 9 7 5  a , b ) . Tyan ( 19 77 )  
reported that aged mice , whose thymuses were involuted , 
exhibited an age-related decrease in T cel l progenitors. 
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Haar et ale ( 198 8 a )  have shown that the ab i l ity o f  bone 
marrow cel ls  of senescent mice to migrate to thymus 
supernatant in v itro i s  greatly reduced . Thi s  migration 
was restored to youthful l evel s  by the engra ftment o f  
thymic ep ithe l i a l  cel l s  from neonatal mice into 24 month 
old mice . S imil arly , athymic nude mice (AKR/J_nustr/nustr) 
have a depressed in v itro migration of bone marrow cel l s  
to thymus supernatant wh ich can b e  restored by the gra fting 
o f  thymic ep ithel ia l  cel l s  into the nude m ice ( Haar et a l . ,  
198 8b)  . Koninkx et ale  ( 19 8 6 )  found that thymus 
supernatant fraction 5 could induce the express ion o f  TdT, 
an immature lymphoid cel l  marker , on the bone marrow ce l l s  
o f  athymic rats . These results strongly support the 
content ion that thymic factors act on bone marrow cel l s  and 
may be necessary for the d i fferent iation o f  prothymocyte s  
in the bone marrow . 
A de f iciency in the hemopoietic stem cel l  compartment o f  
the bone marrow has been postul ated a s  a possible cause o f  
the decl ine i n  immune function with age ( Tyan , 1 9 7 7 ; Go z es 
et a l . ,  1 9 8 2 ) . There have been confl ict ing findings a s  to 
the status of hemopoiet i c  cel l s  in senescent an ima l s . 
There are several reports o f  studies measuring co lony 
forming units in the spleen ( CFU-S ) in whi ch no d i f fe rence 
between young and old mice was found ( Laj tha et a l . ,  1 9 7 1 ;  
coggle et al . ,  1 9 7 5 ; Harri son et al . ,  1 9 7 5 ; and 
S chol field et al . ,  1 9 8 6 ) . Gozes et a l e ( 19 8 2 ) found no 
d i f ferences between young and old bone marrow in CFU-S 
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ability . However ,  they did detect a significant decline in 
mixed lymphocyte reactions and Con A response ,  at 1 2  
months , in recip ients o f  aged bone marrow . Another study 
found that aged and young bone marrow were equa l ly capab l e  
o f  curing the stem cel l  def i c i ency o f  W/Wv mice ( Boggs et 
al . ,  198 4 ) .  Work with bone marrow cultures showed a 
pattern o f  growth s imilar to Hayfl ick ' s  work with 
fibroblasts , i . e .  decreased cumulative cel l recovery and 
culture survival t ime as donor age increased ( Lipschitz and 
Udupa , 198 4 ) .  Bone marrow cultures have a l so been used to 
reconstitute l etha l ly irrad iated mice . In one study young 
and aged bone marrow were compared for the ir ability to 
produce CFU-S . During the f i rst four weeks o f  culture , 
the aged bone marrow actual ly produced more CFU-S than the 
young bone marrow . This  was reversed a fter four weeks and 
cumulat ive CFU-S over a 13 week period were greater i n  
cul tures of  young bone marrow ( Mauch e t  al . ,  198 2 ) .  
Bone marrow chimeras produced between young and old mice 
us ing Thy1 . 1  and Thy1 . 2  congenic mice have been used to 
investigate the abi l ity of senescent bone marrow cel l s  to 
repopul ate thymus and splenic T cel l s  ( H irokawa et a l . ,  
1 9 8 6 ) . Analys is by flow cytometry revealed fewer donor 
cel l s  were present in the thymuses and spl eens of the mice 
given old bone marrow than in mice g iven young bone marrow . 
The ab il ity to accurately fol l ow donor bone marrow makes 
this  a good method for examining the e ffects o f  thymus 
factors on senescent bone marrow . Also , the abi l ity to 
treat donor bone marrow with thymus factors prior to 
intravenous inj ection makes thi s  an attract ive method for 
eva luat ing thymus - bone marrow interacti ons . 
23 
The goal of thi s  experiment was to evaluate what e f fect 
thymus supernatant has on the abi l ity o f  bone marrow c e l l s  
from senescent mice to repopulate the thymus o f  an 
i rradiated host . We found that the bone marrow from o l d  
mice had a greatly reduced abi l ity t o  repopul ate the thymus 
of  an irradiated host . Further ,  we found that a b r i e f  
treatment of the o l d  bone marrow with thymus supernatant 
s igni f icantly improved its thymus repopulating ab i l ity . 
Materials , Methods 
Anima l s  
Aged CBA male mice  24  months o f  age were obta ined from 
Charles River Laboratories ( Kingston , NY ) through the 
Nat i onal Institute on Aging . AKR/J mal e  mice 6 - 8  weeks o l d  
a n d  CBA/J male mice 2 -6 months old were obta ined from 
J ackson Laboratories ( Bar Harbor , ME ) . Mice were housed 
three per cage . The cages were kept in laminar flow hoods 
on a 12 hour l ight/dark cycl e .  Mice were prov ided w i th 
water and autoclaved Purina mouse chow ad l ib itum . 
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Preparation o t  Supernatant 
Thymus supernatant was prepared by plac ing 3 minced 
neonata l thymuses from CBAjJ mice in 3 ml o f  I scove ' s  serum 
free-media ( GI BCO , Grand I s l and , NY ) in 3 5  mm petri d i shes 
( Falcon , Oxnard , CA) . The tissue was cultured for 4 8  hours 
at 3 7 ° C in a humid atmosphere of 5% CO2 • After the ce l l s  
and debris were pel l eted by centri fugat ion , the 
supernatants were collected , f i ltered through O . 2 2 �m 
f i l ters ( Gelman , Ann Arbor ,  MI ) and stored at -7 0 ° C  
unt i l  used for incubating aged bone marrow cel l s . 
preparation o f  Bone Marrow Cel l s  for I n  vi tro Mi grat ion 
As say 
Young and aged CBA mal e  mice were kil l ed by cervical 
dislocation and the tibias and femurs were removed . The 
bones were crushed with a steri l e  mortar and pestle in cold 
Hank ' s balanced salt solution (GIBCO , Grand Island , NY ) 
with 5 %  BSA . After trans ferring to a test tube , the large 
debris was a l l owed to settl e  for 5 minutes . The rema i n i ng 
cell suspens ion was p ipetted o f f , centri fuged , and the 
erythroid cel l s  were lysed with Gey ' s  lys ing buffer . The 
cel l s  were then washed twice . Fol l owing thi s  the cel l s  
were counted and viabil ity determined by trypan blue 
exclus ion . Aged bone marrow cel l s  were placed in thymus 
supernatant or I scove ' s  media ( GI BCO , Grand I s l e , NY ) at 
3 7 ° C  for one hour a fter which they were resuspended in 
fresh Iscove ' s  media at a concentration o f  5xl06jml . 
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I n  vi tro Migration As say 
Bl i nd wel l  chambers ( Nucl epore , Pleasonton , CA ) were u s ed 
conta ining two chambers each with a volume o f  2 0 0�1 , 
separated by a 5�m pore s i z e  f i lter . Two hundred � l  o f  
thymus supernatant o r  l scove ' s  media was placed i n  the 
l ower chamber and 2 0 0� 1  of bone marrow cel l s  were placed i n  
the upper chamber .  Multiple wel l s  were set up for each 
experimental and control samp l e . The wel l s  were incubated 
for 90 minutes at 3 7 ° C .  Then the bottom chambers for each 
samp l e  type were co l l ected , counted , and percent migrat i o n  
c a l cul ated . 
Preparation of Bone Marrow Cel l s  for In vivo Migration 
The bone marrow cel l s  were prepared as for the in vitro 
assay ( described above ) with the fol l owing addit ions . 
Fol l owing lysis o f  the erythro id cel l s , the rema ining bone 
marrow cel l s  were treated with mAb Thy 1 . 2  ( lCN , Li s l e , l L )  
and incubated for 6 0  minutes a t  4 ° C .  The cel l s  were then 
washed and treated with Low-Tox-M rabbit complement 
( Cedarl ane Laboratories , Ontar i o , Canada ) for 6 0  minutes at 
3 7 ° C  to lyse the mature T cel l s . The cel l s  were washed and 
then resuspended in the appropriate experimental or control 
med i a . Aged bone marrow was p laced in thymus supernatant 
o r  l scove ' s  media at 3 7 ° C  for one hour . Untreated control 
bone marrow cel l s  were incubated in normal sal ine on ice 
unt i l  inj ected . Young bone marrow cel l s  were also  
resuspended in normal sal ine and held on  ice . Supernatant 
and l scove ' s  treated cel l s  were washed after treatment and 
a l l  cel l s  were counted on a hemacytometer and v i ab i l ity 
determined by trypan blue exclus ion . Cel l s  were adj usted 
to a concentrat ion of 2 x 1 07/ml . 
Rec ipi ent Mi ce 
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s ix to ten week old  AKR ma l e  mice were given 6 0 0  o r  8 5 0  
rads ( R ) o f  radiation a t  a rate o f  1 0 0R/minute i n  a Mark I ­
Ces ium 1 3 7  I rradiator ( J . L . Sheperd & Associates , San 
Fernando , CA ) . After i rrad iation , the mice were inj ected 
via the tai l  ve in with 4 x 1 06 bone marrow cel l s  whi l e  
con f i ned in a rodent restra int ( Plas Labs , Lans ing , MI ) . 
Examination o f  Thymus and Spleen for Donor Cel l s  
At the end o f  four weeks the rec ip ient mice ( AKR )  were 
sacri f iced by cervical d i s l ocat ion after which thymuses and 
spl eens were qu ickly removed and we ighed . Cel l  suspens i on s  
were then prepared b y  pass ing the tissue through 1 0 0  mesh 
nyl on cloth , and treated with Gey ' s  lys ing buf fer to remove 
the erythrocytes . Al i quots o f  cel l s  from both thymus and 
spl een were subsequently treated with either Thy 1. 1 o r  Thy 
1. 2 FITC conj ugated monoc l onal antibodies ( leN , Li s l e ,  I L ) . 
A fter labell ing ,  the cel l s  were washed and resuspended in 
PBS for analys i s  by flow cytometry to determine the 
percentage of donor pos i t ive cel l s  ( Thy 1. 2 +) and rad iat ion 
res istant host cel l s  ( Thy 1. 1+ )  in each organ . 
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RE SULTS 
In vi tro 
In the in v itro assay of bone marrow chemotaxi s  it was 
found that incubat i on o f  bone marrow cel l s  in thymus 
supernatant for one hour increased the migrat ion of the 
ce l l s . Migration to thymus supernatant was increased by 
32% (p = 0 . 0 3 )  but the control migrat ion to I scove ' s  med i a  
was not s ign i f icantly ( p  = 0 . 1 1 )  increased by the thymus 
supernatant pre-treatment ( F igure 1 . 1 ) . 
I n  vivo 
I n  the in vivo assay o f  thymus homing abi l ity it was 
determined that bone marrow from senescent mice was 
impaired in its ab i l ity to repopulate the thymus o f  an 
i rradiated host when examined at 4 weeks post transpl ant ( p  
= 0 . 0 2 7 )  ( Figure 1 . 2 ) . Our assay did not show a 
s igni f icant di f ference between bone marrow from young and 
aged mice in the i r  ab i l ity to repopu l ate the spleen w ith 
mature T cel l s  at thi s  same t ime interval ( F igure 1 . 3 ) . 
Treatment o f  the aged bone marrow cel l s  with a one hour 
incubation in thymus supernatant prior to inj ect ion 
resulted in a dramatic improvement in the ab i l ity o f  
senescent bone marrow t o  repopul ate the thymus o f  an  
irradiated host ( p=0 . 0 3 1 )  ( Figure 1 . 4 ) . The abi l ity o f  the 
thymus supernatant treated bone marrow to reconst itute the 
thymus was improved to a level that was not s igni ficant l y  
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d i f f e rent from that o f  yot ng bone ma rrow ( F igure 1 . 5 ) . 
From the s e  data it appears that the sene s c ent bone ma rrow 
has been re stored to youthful l eve l s  of funct ion a s  regard s  
thymus s eeding ab i l i t i e s . 
Treatment o f  aged bone marrow cel l s  with r scove ' s  med i a , 
the media base f o r  the supernatant , d id not improve the i r  
thymus repopul ating abi l ity over that o f  untreated aged 
bone marrow ( p= O . 2 6 )  ( Figure 1 . 6 ) . There was no d i f ference 
between young and aged bone marrow cel l s  in their ab i l ity 
to seed the spleen with mature T cel l s  at this time In 
addit ion , treatment of  aged bone marrow ce l l s  with thymus 
supernatant prior to injection had no e f fect on the ir 
ab i l ity to repopu l ate the spleen with mature T cel l s  
( F igure 1 . 7 ) . 
There was s ign i ficant variabil ity in the thymus 
repopulat ing abil ity o f  the bone marrow from young mice as  
wel l  as from aged mice . One of the factors which was 
found to a f fect the thymus repopulating abi l ity was the 
numbe r  of radiation res i stant host cel l s  in the thymus . 
Typ ical results are shown in Table 1 . 1 .  As  these figures 
cl early demonstrate ,  h igh numbers o f  host ce l l s in the 
thymu s p rec l ude repopulation regardless of the source o f  
the bone marrow . However ,  the infer iority o f  the aged 
bone marrow compared to young bone marrow was cons istent a s  
was the improvement with thymus supernatant treatment . The 
consistency of the thymus repopul at ing ab ility of the 
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T ab l e  1 . 1 .  Rad i at i on Res i stant Ho s t  C e l l s  ( Thy 1 . 1 ) and 
C e l l s  ( Thy 1 . 2 )  as % of Thymocyt e s  a t  Four Weeks 
I r r a d i at i on . Repopu l a t i on i s greater i n mi c e  where hos t  
a r e  f ew regard l e s s  o f  the source o f  donor c e l l s . 
Rads ll Thy Young Old Old Treated 
1 . 1  3 4 . 2  7 1 . 8  6 3 . 8  
6 0 0  
1 . 2  2 4 . 9  0 . 6 8 2 . 6 9 
1 . 1  1 . 5 1 1 . 3 5 0 . 6 4 
8 5 0  
1 . 2  8 5 . 4 3 4 3 . 5 2 8 9 . 5 5 
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Donor 
P o s t ­
ce l ls 
3 7  
T able 1 . 2 .  Thymus Repopul ating Ability f or All Experiments 
Expressed as a Rati os of  Percent age of Don or +  Thymoc ytes. 
Young : Old Old Treated: Old 
x 2 8 . 2 0 3 . 9 6 
an 2 4 . 8 6 2 . 6 7 
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d i f ferent bone marrow populations i s  c l ear when one 
expresses the results of  a l l  the experiments , regard l e s s  o f  
radiation exposure and number o f  rad i at i on res i stant host 
cel l s  in the thymus , as a rati o  ( Tabl e  1 . 2 ) . I f  the 
groups are s imilar the rat io obviously would be equal to 
one or nearly so . As can be seen in Tab l e  1 . 2 ,  thi s  i s  
not the case . Both the ratio o f  young : old and old 
treated : o ld are s igni ficantly greater than one . 
DI SCUSS ION 
Our results indicate that there is some factor in the 
thymus supernatant that improves the thymus homing ab i l ity 
of  senescent bone marrow cel l s . Treatment o f  bone marrow 
from senescent mice with thymus supernatant restored the 
ab i l ity of these cel l s  to migrate to both thymus 
supernatant in v itro and to the thymus i n  v ivo . The fact 
that I scove ' s  media , the media base for the thymus 
supernatant , did not improve the thymus repopulating 
abi l ity o f  the aged bone marrow ind i cates that the 
improvement is due to a factor produced by the thymus 
cultures . 
It is  known that the radiation res istant host thymocyte s  
prol i ferate in  the thymus and reseed the periphera l  
lympho id organs a fter irradiation ( H irokawa e t  a l . ,  1 9 8 5 ) . 
In a previous study it was determined that in bone marrow 
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ch imeras the donor-type T cel l s  first repopul ate the thymus 
and then emigrate to peripheral lymphoid t i s sues ( H i rokawa 
et a l . ,  1 9 8 6 ) . The donor-type T cel l s  were f i rst detected 
in the spl een at 1 4  days and the d i fference i n  the numbe r  
o f  donor cel l s  from young and aged donor cel l s  was not 
determined unti l  28  days . The percentage o f  donor-type T 
ce l l s  in the spleens o f  i rradi ated mice was not 
s igni f icantly d i f ferent between young and aged donors unt i l  
5 6  days . S imilarly , in the present study it was not 
p os s ible to detect a difference in the percentage of donor­
type cel l s  from young and old donors in the spl een at 2 8  
days . Nor could we detect any d i f ference in the ab i l i ty o f  
old bone marrow and thymus supernatant treated o l d  bone 
marrow to generate splenic repopulat ion . Thi s  i s  probabl y  
due to the l ow numbers o f  donor derived T ce l l s  present i n  
the spleen a t  this  time . The di f ferences that are seen i n  
the thymus have yet t o  man i fest themselves i n  the sp l een 
s ince the number o f  mature T cel l s  that have been exported 
to the peripheral lymphoid t i s sues is sti l l  too l ow at thi s  
t ime a fter irradiat ion . 
The present study alone does not reveal whether the factor 
respons ible for ma inta ining T cel l  precursors in the bone 
marrow i s  a previous ly unident i fied factor produced by the 
thymus . It  i s  pos s ible that we have di scovered another 
funct ion o f  previously isolated thymus products such a s  
thymul in , thymopoietin , o r  one of the thymos ins . S ince 
the production of these thymus factors is  decreased in 
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later l i fe ,  ( Lewis  et al . ,  1 9 7 8 ; Goff  et al . ,  1 9 8 7 ; 
Oosterom and Kater , 1 9 8 1 ; Bach et al . ,  1 9 7 5a , b ) thi s  wou l d  
exp l a in the decreased function o f  bone marrow T cel l 
precursors cel l s  from senescent mice . Thymus cultures 
produce nonun ique p roducts ( e . g .  ubiquitin and general 
metabol ic products ) which need to be excluded be fore a 
de f initive statement can be made . Further stud ies w i l l  be 
necessary to determine what factor is  respons ible for the 
thymus 's apparent modulation of T cel l progenitors in the 
bone marrow . 
The rol e  o f  the thymus in the development o f  the immune 
system has yet to be ful ly elucidated but the decreas e s  in 
known thymus factors with age has been c l early documented 
as has the ir beneficial  e ffect on the senescent immune 
system ( Bach et al 1 9 7 5a , b ;  Bach , 1 9 7 7 ; Cowan et a l . , 19 8 1 ; 
Erschler et al . ,  1 9 8 5 ; Frasca et al . ,  1 9 8 6 ; Frasca et 
al . , 19 8 7 ; Gof f  et a l . ,  19 8 7 ; Erschler et a l . ,  1 9 8 9 ) . 
The recogn it ion o f  the thymus ' s  influence on bone marrow 
cel l s  may be one step toward a more thorough understand i ng 
of the deve lopment o f  the immune system a s  wel l  a s  its 
senescence . 
It has been shown here and previously ( Tyan , 1 9 7 7 ; 
Hirokawa , 1 9 8 6 )  that the T cell precursors in the bone 
marrow o f  senescent mice have a decreased ab i l ity to seed 
the thymus . Previous work in this laboratory with 
immunode ficient mice ( athymic nude mice and 2 4  month o l d  
aged CBA mice ) has demonstrated that there is  an 
imp a i rment in the in vitro migrati on o f  the bone marrow 
ce l l s  in response to thymus factors ( Haar et al . ,  
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1 9 8 8 a , b ) . In  addition , these stud ies showed that thym i c  
epithe l ial cel l  gra fts were capabl e  o f  restoring the in 
vitro migration o f  bone marrow cel l s  to thymus supernatant 
to normal l eve l s  as wel l  as improving cel lular immune 
funct i on . Those results alone i nd icated that the thymus i s  
t o  some extent respons ibl e  for the maintenance o f  bone 
marrow cel l s  in add it ion to its rol e  in the deve l opment o f  
a competent immune system . In the context o f  the present 
study , those previous experiments l end further support to 
our conclus ion that thymus derived factors are respons ib l e  
for the ma intenance o f  T cel l  precursors i n  the bone 
marrow . 
Previ ous work on the e ffects o f  thymus derived factors have 
somet imes overstated the unique propert ies o f  these 
factors .  There fore we are cauti ous in our interpretat ion 
o f  the above findings . However ,  s ince the T cel l  
progenitors i n  the bone marrow o f  senescent mice are 
impa ired , it i s  only l ogical to attribute the impairment 
and its rej uvenation to a factor known to be reduced in 
advanced age . We therefore claim that it is both pos s ib l e  
and l ikely that the decreased ab i l ity of T cel l precursors 
from the bone marrow o f  senescent mice to repopul ate the 
thymus is the resul t  of a loss of necessary tonic thymus 
factors acting on the bone marrow cel l s . 
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Whi l e  there have been several studies on the e f fects o f  
i rradiat ion on the status o f  bone marrow ce l l s  ( Boggs e t  
a l . ,  1 9 6 7 ; Harrison and Astle , 1 9 8 2 ) , the e f fect o f  
who l e  body irradiation o n  the thymus has not rece ived such 
attent ion . From thes e  results it appears that in order for 
s ign i f icant repopulat i on o f  the thymus to occur the 
res ident thymocyte popu l at ion must be el iminated . I t  
rema ins t o  b e  determined what the spec i f ic characte r i s t i c s  
o f  the radiat ion res istant population of thymocytes are . 
Are they more mature? Are the radiat ion res istant cel l s  
the same populat ion as the cort i sone insensit ive cel l s ?  
Are they loca l i z ed in the cortex o r  the medu l l a ?  The 
answers to these questions might help us to more ful ly 
understand what happens to thymocytes during thei r  
res idence i n  the thymus . 
The status of  bone marrow stem cel ls in senescent anima l s  
i s  a matter on which there i s  some disagreement . One o f  
the reasons for disagreement among invest igators i s  the 
incomplete knowledge of hematopo ietic d i f ferentiation o f  
bone marrow stem cel l s  even i n  non-senescent an ima l s . 
S ince it is not pos s ib l e  to isolate hematopo ietic stem 
cel l s , numerous indirect assays o f  varying spec i f ic i ty have 
been employed . The speci f ic ity o f  d i fferent assays for 
pluripotent versus committed progenitor cel l s  i s  unclear . 
A recent review by Spangrude ( 19 8 9 ) discusses thi s  probl em 
and the s igni ficant advances that been made toward 
isolat ion of murine hemopo ietic stem ce l l s . The 
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d i f f iculties involved in the spec i fic ity o f  stem cel l  
assays have l ed t o  a second problem i n  the interp retat ion 
o f  such experiments in senescent anima l s , a fai lure to 
dist inguish among d i f ferent progenitor cel l s . Totipotent 
stem cel ls  may be un impa ired with age but progenitor cel l s  
for spec i f ic l ineages may not be a s  wel l  preserved . 
Fai lure to distingu i sh between these d i f ferent categories 
o f  cel l s  has led to apparent contradict i ons . For examp l e , 
Harrison has shown through some excel l ent studies that 
erythrocyte progenitors are not impa i red with age ( Harri son 
and Astle ,  1 9 8 2 ; Harri son et al . ,  1 9 8 4 ) . I t  would be 
incorrect , however ,  to extend these results to a l l  
progenitor cel l s  or pluripotent hematopo i etic stem cel l s . 
Erythrocytes must be replenished constantly due to the 
brief li fespan o f  the ful ly differentiated red blood cel l s . 
Exhausted red bl ood cel l s  must be replaced through cel l s  
less differentiated than mature erythrocyte s  s ince the 
ful ly di fferenti ated red blood cel l  is i ncapabl e  o f  
repl icat ion . T cel l s  are known , however ,  to have l i fespans 
that may be as l ong as a decade or more . I n  addit ion , 
ful ly mature T cel l s  are capable o f  mitot i c  d ivis ion . 
Therefore , because the T cel l  progenitor i s  not necessary 
for mainta ining the normal population o f  mature cel l s , it 
would not be surpri s ing to learn that the T cel l  progenitor 
is impa ired or even l ost in advanced age . S ince the 
progenitor cel l s  would not be cal led upon a fter the immune 
system had been ful ly established ,  such an impairment might 
be insignif icant for normal immune funct ion . For th i s  
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reason , we cons ider it unl ikely that a de f i c iency i n  the T 
cel l progenitor i s  a maj or factor in the dec l ine o f  
cel lular immune funct ion with age ; we do cons ider thi s  t o  
be a poss ibl e  contribut ing factor . However ,  the maj o r  
benefit derived from investigating the status o f  the T ce l l  
progenitor in senescence i s  to more ful ly understand the 
variety of stem cel l s  in the bone marrow and to more 
comp l etely comprehend the senescent state . 
Chapter Two 
The E f fects o f  Anterior Pituitary 
Hormones in Senescent Mi ce 
I nteract ions between the endocrine system and the immune 
system have been reported with increas ing frequency over 
the l ast two and a hal f decades . One o f  the earl iest 
endocrine- immune system interact ions was noted at the s ame 
t ime that the role of the thymus in immune function was 
being elucidated . Takemoto et al e ( 19 6 2 ) reported that 
growth hormone causes an enlargement of the thymus . 
Another significant ins ight into the endocrine - immune 
rel at i onship occurred when Pierpaol i and Sorkin ( 19 6 7 ) 
reported that p ituitary deficiency caused wast ing d i sease , 
a syndrome normal ly associated with neonatal thymectomy . 
Subsequent to making thi s  serendipitous finding , they 
treated young mice with " anti-hypophys i s  serum" whi ch 
resulted in thymic involution and premature death . 
As the fol lowing studies i l lustrate , experimenta l  evidence 
indicates that the immune system is closely l inked to the 
endocrine system via the thymus . The l i fe span o f  short­
l ived dwarf mice can be extended by the inj ection of growth 
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factors and thyrox ine but not i f  the thymus has been 
removed ( P iantanel l i  and Fabris ,  1 9 7 7 ) . S everal studies 
have indicated that the thymus or thymus products can 
modulate hormone l eve l s  includ ing lute i n i z ing hormone , 
tri iodo- thyroxine , and insul in ( Fabri s  et a I , 1 9 7 2 ; 
Piantanel l i  et al . ,  1 9 7 8 ; Rebar et a l . ,  1 9 8 1 ) . However ,  
the mechan ism o f  such regulation is not understood . I t  has 
also been observed that neonatal  thymectomy results in the 
degranulation of the acidophils  of the anterior p ituitary ; 
thes e  are the cel l s  respons ible for the product ion o f  
growth hormone and prolactin ( Pierpaol i  and Sorkin , 1 9 6 7 ) . 
More recent work indicates that anterior pituitary hormones 
may be able to reverse , at least part i a l ly , some of the 
immune dys function seen in senescent anima l s  ( Roth et a l . ,  
1 9 8 4 ; Kel l ey et a l . ,  1 9 8 6 ; and Gof f  et al . ,  1 9 8 7 ; Monroe 
et al . ,  1 9 8 7 ) . By treating various aged dogs with bovine 
growth hormone , it was found that growth hormone resulted 
in a rej uvenation of the thymic morphology o f  middle-aged 
( 3 3 - 3 5  months ) dogs . Thymus mass was increased , cort ical 
and medull ary regions were clearly def i ned , and fatty 
infiltrat ion was minimal ( Go f f  et al . ,  1 9 8 7 ) . It was a l so 
determined that serum level s  of thymul in are decreased with 
age and that growth hormone treatment increased the l evel 
o f  thymul in in aged dogs . Earl ier , Fabri s  and Mocchegiani 
( 19 8 5 )  had reported decreased levels o f  thymul in with age 
and variat ions in thymul in levels with endocrine 
imba lances . 
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Ke l l ey et al e ( 1 9 8 6 )  have reported s imilar restorat ion o f  
thymus structure and cel lular immune function in 1 8  and 2 4  
month old rats given GH3 p ituitary adenoma cel l s  which 
secrete both growth hormone and pro l act in . The GH3 cel l s  
were imp lanted subcutaneously and the anima l s  sacr i f iced 
approximately two months l ater . Whi l e  the 1 8  month o l d  
rats ach ieved a greater degree o f  rej uvenat ion , both 1 8  
and 2 4  month old GH3 treated rats showed a n  improvement i n  
thymus morphol ogy and cel lular immune response . 
The current study invest igated the abi l ity o f  growth 
hormone to rej uvenate the age-involuted thymus and to 
restore the senescent immune response in 24 month old mice . 
Three means of  del ivering growth hormone to senescent mice 
were employed . The first method used GH3 cel l s  encl osed i n  
M i l l iporeR d i f fus ion chambers . The second method was da i ly 
inj ect ions of  ovine growth hormone . T imed release pel l et s  
o f  ovine growth hormone implanted subcutaneously was the 
thi rd method of hormone treatment . At the end of the 
treatment period , thymus mas s  and morphology were 
eva luated and assays of cel lul ar immune function were 
performed . Al l anima l s  were examined for gross pathol og i e s  
at the end o f  the treatment peri od . Aberrant organs were 
removed and pathological eva luat ion was performed by 
qual i f ied personnel . 
Materi al s and Methods 
Anima l s  
CBA mal e  mice 2 4  months o f  age were obta ined from Charles  
River Laboratories ( Kingston , NY ) through the National 
Institute on Aging . Mice were housed 3 per cage . The 
cages were kept in l aminar flow hoods on a 12 hour 
l ight/dark cycle .  Mice were p rov ided with water and 
autocl aved Purina mouse chow ad l ibitum . 
GH3 Cel l s  
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GH3 cel l s  are derived from rat p ituitary adenoma and they 
secrete both growth hormone and prolactin . Kel l ey et a l e 
( 19 8 6 )  inj ected these cel l s  into the peritoneal cavity o f  
senescent rats a s  a source o f  anterior p i tuitary hormones .  
S ince the present study was conducted in mice , thi s  
technique was not feas ibl e .  Rat MHC ant igens would be  
recogn i z ed as fore ign by the mouse . By placing the GH3 
cel l s  in diffus ion chambers ( Mi l l ipore , Bedford , MA )  the 
cel l s  were protected from immunological attack by the host 
( mouse ) . At the same t ime this  technique a l l owed GH3 cel l  
products to diffuse into the peritoneal cavity and be 
absorbed by the mouse . The GH3 cel l s  used in thi s  
experiment were the generous gift of Dr . Robert Adler . 
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Di f fu s i on Chambers 
Materials  required for the assembly of d i f fusion chambers 
( DC )  were obta ined from Mi l l ipore Corporat ion ( Bedford , 
MA) . The DC were composed o f  luc ite rings 1 3 mm  in 
diameter , 0 . 2 2�m pore membrane f i lters , and cement for 
attaching the membranes to the rings . The membranes were 
pl aced in boi l ing water for 5 m inutes prior to use to 
remove any surfactants . After dry i ng , a membrane was 
attached to one s ide o f  the luc ite ring . When the glue had 
dried , the hal f compl eted DC and unattached membranes were 
steri l i z ed by irradiation . Under ster i l e  condit ions GH3 
cel l s  were added to the part i a l l y  a ssembled DC . Some o f  
the media was allowed to d i f fuse out o f  the chamber , a fter 
which glue was appl ied to the lucite r ing and the second 
f i l ter was attached to seal the chamber . When the glue had 
dried ( approximately 10 minutes ) the DC containing the GH3 
cel l s  were ready for implantati on i n  the mouse . The DC 
were cultured in 2 ml of medi a  for 2 4  hours a fter which the 
media was examined for cel l s  to further confirm the 
integrity of the seal of the membranes .  An acidic change 
in the pH of the media was taken to ind icate viab l e  cel l s  
i n  the DC . The DC were washed with serum free med i a  prior 
to impl antation . 
Surgery 
Mice were anestheti zed with tribromoethanol ( 0 . 2ml/ 1 0 g  body 
we ight , 2 0mg/ml ) .  DC were inserted in the superior aspect 
o f  the peritoneal cavity via a 1 3 - 1 5mm inc is ion . The 
i nc i s ion was then cl osed with two l ayers o f  sutures 
( peritoneal and dermal ) .  At the end of  the 4 week 
treatment period , the mice were sacr i f i ced by cerv i c a l  
d i s l ocation . 
Antigen priming 
PS 1 5  tumor cel ls  were irradiated with 1 0 0 0  rads and an 
inoculum of lxl07 was administered I . P . in 0 . 5  ml o f  PBS . 
The mice were sacrificed by cervical dislocation 1 0  days 
a fter PS 1 5  priming . 
Hi s to l ogy 
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Thymus glands fixed i n  neutral buf fered formal in were 
dehydrated in graded alcohols ,  infiltrated and embedded i n  
JB-4 embedding plastic . sections 3 -5�m thick were cut and 
sta i ned with hematoxylin and eos in for l ight microscopy . 
cytotoxicity Assay 
spl eens from experimental and control animals were removed 
ster i l ely , cell suspensions prepared , erythrocyte s  lysed 
and the remaining cel l s  were washed . The cel l s  were 
cultured at a concentration of 5xl06 
cel l s/wel l in a 2 4  wel l  flat bottomed p l ate ( Costar , 
Cambridge , MA ) with 0 ,  2 ,  or 6 �m o f  Con A /ml per group 
of cel l s  and 3 wel ls per dose in 1 ml of media ( RPM! + 1 0 %  
serum , lxPen/strep , sodium pyruvate ,  nonessential amino 
acids , and 2 -mercaptoethanol ) . Pl ates were incubated for 
40 hours at 3 7 - C  in 5 %  CO2 _ Cel l s  were harvested by 
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vigorous p ipett ing . Fol lowing centri fugat ion , the 
supernatants were col lected and stored fro z en for future 
analys i s  in the I L- 2  assay . These cultured e f fector cel l s  
were pl ated t o  yield e ffector-target cel l  rat ios o f  5 0 : 1 ,  
2 5 : 1 , 1 2 . 5 : 1 , 6 . 2 5 : 1 ,  and 3 . 1 2 5 : 1  in a 9 6  wel l  flat 
bottomed plate ( Costar ) . 5 0  � l  o f  PHA ( 1 0 0�g/ml ) was added 
to the cultures j ust prior to adding the 51Cr labe l l ed P8 1 5  
target cel l s  ( 5X105 cel l s/wel l ) . The plates were gently 
agitated be fore being incubated at 3 7 ° C  in 5 %  CO2 for 5 
hours . The supernatants were harvested with a Skatron 
Harvest ing Press and counted in an LKB automatic gamma 
counter . 
Con A stimul ation 
The media used for the assay was the same as for the 
cytotoxic ity assay . Final doses o f  Con A were 0 ,  0 . 67 ,  2 ,  
6 ,  1 8 , and 5 4  �g/ml . Each dose was plated in tripl icate in  
a 96  wel l  plate . Spleen cel l s  were plated at 
1 . 2 5x 1 06/wel l .  The plates were cultured for three days at 
3 7 ° C  in 5% CO2 , The plates were then pul sed with 3H 
thymidine ( l�Ci/wel l ) , incubated for 7 hours , and harvested 
with a Skatron Cel l Harvester onto f i lter paper . The cel l s  
were counted in a Beckman LS 7 5 0 0  l iquid scint i l l at i on 
counter . 
I L- 2  Assay 
supernatants from the spleen cel l cultures used in the 
cytotox ic ity assay were evaluated for the presence o f  I L- 2  
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a s  fol lows . Several two- fold d i lut ions o f  the supernatant 
and a standard I L-2  solution were al iquoted in trip l icate 
in 96 wel l  U-bottom plates ( 0 . 1  ml/wel l )  and 1 04 I L- 2  
dependent CTLL cel ls  were added per wel l . The p l ates were 
cultured for 20  hours at 3 7 · C  i n  5 %  CO2 , then pul s ed with 
3H thymidine and returned to the incubator for 6 hours . 
The cel ls  were harvested onto f il ter paper with a Skatron 
Cel l  Harvester and counted in a Beckman LS 7 5 0 0  l iquid 
scint i l l ation counter . 
Radi o immunoassay 
Bl ood from the mice implanted with the DCs containing GH3 
cel l s  was obtained by severing the axil lary artery a fter 
anesthet i z ing the mouse . Approximately 0 . 5 - 1 . 0  ml o f  b lood 
was obtained from each mouse , placed in 1 . 5  ml prov ia l s  
( Costar ) and hel d  at -7 0 · C .  RIA was conducted with the 
doub l e  ant ibody technique and the use of kits provided by 
the NI DDK . Anti -rat GH serum 5 - 4  was used with rat GH RP-
2 as the re ference preparat ion . 
GH Inj ect ions 
Mice were g iven da ily intraperitoneal inj ections of e i ther 
5�g of ovine growth hormone ( NI DDK) in 2 0 0�l of normal 
sal ine or a control inj ect ion of  2 00�l o f  sal ine for 3 0  
days . 
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GH Timed Rel ease Pel l ets 
T imed re lease pel l ets of ovine growth hormone ( NI DDK) were 
p repared by Innovat ive Research of America ( To l edo , OH ) . 
Thes e  pellets each conta ined 7 5�g o f  growth hormone whi ch 
was released at a constant rate over a period o f  1 5  days 
( i . e . 5�g per day ) . Pel l ets were impl anted subcutaneously 
us ing a trochar ( IRA , Tol edo , Oh io ) every 1 5  days for a 
tota l treatment period o f  6 0  days . Control anima l s  were 
s im i l arly treated with placebo pel l ets which were ident ical  
i n  compos ition except for the growth hormone . 
Necropsy 
Al l mice were examined at the t ime of sacr i f ice , prior t o  
the removal o f  the thymus and spleen , for gross 
pathol ogies . 
RESULTS 
GH3 Cel l s  
The mice which received the GH3 cel l s  i n  d i f fusion chambers 
did not exhibit an increase in the ir thymus mas s  and 
morphol ogy or improved cellular immune function . Upon 
h i stological examination , the GH3 cel l s  appeared t o  be 
hea lthy and functioning . However ,  the radi o immunoas s ay did 
not detect rat ( i . e .  GH3 derived ) growth hormone in  the 
serum of the mice implanted with GH3 conta ining d i f fu s i on 
chambers . 
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GH Inj ections 
The mice which received da ily inj ect ions of growth hormone 
for 3 0  days did not exhibit improvement in the ir thymus 
mass and morphol ogy . Hi stological examinat ion o f  the 
thymuses reveal ed no d i f ference between the growth hormone 
treated and sal ine treated mice F igure 2 . 1 . Both groups 
had involuted thymuses which l acked dist inct cortical  and 
medul lary areas . A few thymuses conta ined cysts f i l l ed 
with col l o id appearing material and bounded by a plump 
cuboidal epithel ium . In some instances the col l o id-l ike 
substance had a l ame l lar appearance . Although such 
mUlticyst ic thymus glands are not an unusual f inding i n  
human autops ies ( Rosa i and Levine , 1 9 7 6 ) , w e  have not seen 
previous re ference to this pathology in mice . There was no 
difference between the experimental and contro l  mice in 
thei r  cel lular immune response . Hepatocel lular adenomas 
were found in  6 7 %  o f  the growth hormone treated mice 
( described in further deta il bel ow )  but none o f  the sal ine 
treated mice exh ib ited abnormal l ivers . 
GH Pel l ets 
Thymus Mas s 
Al l o f  the growth hormone treated mice exh ib ited at least 
some grossly distinguishable thymus tissue . Two o f  the 
placebo treated mice had no grossly dist inguishab l e  thymus 
and the thymuses o f  the rema ining control mice were 
severely involuted . The mass o f  the thymus was 
sign i f icantly greater in the growth hormone treated m i ce 
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F I GURE 2 . l a :  Thymus o f  Twenty - f our month o ld mou s e  g iven dai ly 
inj e c t i ons of ov ine growth hormone for one month . Note the 
inf i lt r at i on of f atty c onnect ive t i s sue ( A )  and l a c k  of 
di s t inct cor t i c a l  and medu l l ary regions . I n  thi s particular 
anima l the thymus cont a i ned cys t s  f i l led with c o l l o i d - l i ke 
mate r i a l  ( C ) ( en l a r ged i n  i n s e r t ) .  ( l OX . I n s e r t  4 0X ) . 
F i gu r e  2 . lb :  Thymus o f  a twenty- f our month o ld mous e  g iven 
d a i ly inj e c t ions o f  s a l ine for one month . The r e  i s  no 
d i s t inc t i on be twee n  the c o r t i c a l  and medu l l ary d i s t r i but ion 
o f  lymphocyte s ( L )  and f at ty conne c t ive t i s sue is i nvading the 
parenchyma ( A ) . ( 6 . 3 X ) . 
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compared to the p l acebo treated mice ( p=O . 0 0 2 ) ( F igure 
2 . 2 ) . 
Thymus Hi stology 
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H i stological examinat ion o f  the thymuses reveal ed 
morphol ogical features s imilar to young adult , in the 
growth hormone treated mice . I n  contrast , the control mice 
exhib ited severely involuted or indistingu ishab l e  thymus 
morphol ogy typ ical o f  thei r  advanced age . Al l but one o f  
the growth hormone treated mice ( G2 )  had dist inct cort ic a l  
and medu l l ary regions . Wh i l e  the thymuses o f  the growth 
hormone treated mice possessed good morphol ogy ( except G 2 ) , 
they were not uni form . The thickness o f  the cortex and the 
degree of fatty connective t i s sue infiltration of the 
parenchyma varied even in the thymuses with good 
morphology . Al so variable was the medu l lary region . Two 
of the growth hormone treated mice had large ves s e l s  in the 
medul la . However ,  in a l l  but one animal ( G2 ) normal thymus 
histology was clearly evident . None o f  the control mice ' s  
thymuses exh ibited a distinct cortex and medul l a . The 
placebo treated mice exhibited extreme fatty inf i ltrati on 
o f  the organ which could be described as a col l ect ion o f  
lymphoid nodules interspersed among fatty connective t i s sue 
( Figure 2 . 3 ) . 
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Cel lular Immune Function 
Con A Pro l i feration Response 
The results o f  the Con A prol i ferati on are shown in F igure 
2 . 4 .  As the figure indicates the Con A response was h ighl y  
var iab l e . statist ical ana lys is us ing a repeated measures 
analys i s  o f  variance ( SAS , 1 9 8 5 )  reveal ed no s ign i f icant 
di f ference in the Con A response between the growth hormone 
treated and the pl acebo treated animal s .  The unstimul ated 
prol i ferat ion level ( Con A = 0 )  and Con A stimul ated 
pro l i ferat ion response at 6�g/ml were higher in the growth 
hormone treated animal s .  These d i fferences were 
s igni f icant when analyzed us ing a paired T -test but were 
not stat istica l ly significant under the more rigorous 
conditions of ANOVA . 
CTL Activi ty 
There was no d i f ference between the growth hormone treated 
mice and the pl acebo treated mice in  the i r  cytotoxic T 
lymphocyte act ivity as measured by the i r  abil ity to lyse 
51Cr labe l l ed P8 l 5  tumor cel l s . 
I L- 2  Production 
Product ion o f  I L-2 by cultured splenic T cel l s  stimulated 
with Con A was assayed by the abi l ity of the col l ected 
supernatants to promote the growth of the I L- 2  dependent T 
cel l l ine CTLL . There was no d i fference between the growth 
60 
F igure 2 .  3 a : Thymus o f  a twenty- four month old mice wh i ch 
recei  ved t imed-release growth hormone pel lets for eight weeks . 
Note the dist inct cort ical ( C )  and medul lary ( M )  regi ons . 
Wh i l e  not ident ical to a typical young thymus its morphol ogy 
is markedly better than the typical 2 4  month old murine 
thymus . ( 4 X ) . 
F i gure 2 . 3b :  Thymus o f  a twenty- four month old mouse whi ch 
rece ived pl acebo tablets for e ight weeks . Note the extens ive 
i n f i l trat i on o f  fatty connect ive tissue ( A )  and the l ack o f  
d i st i nct cortical and medu l l ary regions . ( 4 X ) . 
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hormone treated mice and the control mice i n  the i r  I L- 2  
product ion . 
Pathologi cal Findings 
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The inc idence o f  hepatocel lular adenomas was extreme l y  h igh 
in the GH treated mice when compared to control mice . The 
inc idence o f  tumors in the mice given GH pel l et s  was 6 7 % . 
There were no hepatocel lular tumors in the control 
population . The fol l owing pathological descript i on app l i e s  
t o  the tumors found in both the growth hormone inj ected 
mice and the growth hormone pellet treated mice . The 
adenomas varied in s i z e  from small tumors severa l 
m i l l imeters in diameter to large tumors encompass ing an 
enti re lobe or more . Examination revea l ed a wel l  de f i ned 
nonencapsulated mass with superficial vessels  and 
p igmentation sl ightly darker than normal hepat ic t i s sue . 
Histological examinat i on showed the tumor to be  composed o f  
sl ightly abnormal hepatocytes . The hepatocyte cytop l a sm 
was more eos inoph il ic and the nucle i were up to  1 . 5  t imes 
normal hepatocytes with open chromatin and prominent 
nucleol i .  Occas ional cel l s  were b inucl eate . The ce l lu l a r  
arrangement was that o f  i rregularly anastomos ing cords . 
There was no evidence o f  lobular architecture and there 
were no portal triad s  or central veins ( F igure 2 . 5 ) . 
Two of the mice which had hepatic adenomas a l s o  had 
pulmonary adenocarcinomas ( G2 and G6 ) . These tumors 
exhib ited characteristics of spontaneous mouse lung tumors 
and were j udged to be unrelated to the hepat i c  tumors 
F igure 2 . 6 ) . It should be noted that one o f  the mice 
hav ing a lung tumor was the mouse whi ch did not exh i b i t  
thymic rej uvenat ion ( G2 ) . The other mouse with a lung 
tumor ( G6 )  had a thymus with a thin cortex but was 
otherwise typical of the growth hormone treated mice . 
DI SCUSS ION 
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The absence o f  rat growth hormone i n  the serum o f  the mice 
g iven d i f fusion chambers with GH3 cel l s  was qu ite 
unexpected . It  is  unl ikely that the rat growth hormone was 
recogn i z ed as fore ign and hence el iminated s ince there i s  
an extremely high degree o f  conservati on exh ib ited across 
species . A more l ikely explanation i s  that the s l ow 
d i f fus ion o f  GH3 produced growth hormone and prolact in out 
of the d i f fusion chambers led to a high local concentrat ion 
of growth hormone and prolactin which down regul ated the 
production of these prote ins . The end result was that only 
negl igible amounts of growth hormone and prolactin were 
produced . 
The results o f  the exper iments in which growth hormone 
pel l ets were inj ected support earl ier reports in other 
species that it i s  poss ible to rej uvenate the senescent 
thymus in v ivo ( Kel ley et al . ,  1 9 8 6 ; Gof f  et a l . ,  1 9 8 7 ; 
Monroe et al . ,  1 9 8 7 ) . The present study indicates that the 
treatment period required to attain such a rej uvenat ion i n  
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Figure 2 . 5 : Hepatic adenoma found i n  6 7 %  o f  growth hormone 
treated mice . Area to the right of micrograph ( H )  i s  norma l 
hepatic tissue ; the tissue to the left i s  adenoma ( T ) . Note 
the darker sta ining and enlarged hepatocytes in the tumor 
area . ( 2 0X ) . 
Figure 2 . 6 : Lung Tumor found in two o f  the growth treated 
mice . Note the galndular appearing tumor tissue ( T )  which has 
d i spl aced the normal respi ratory t issue o f  the alveolus ( L) . 
( 20 X )  . 
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mice i s  approximately 8 weeks . This conclus i on i s  bas ed o n  
the lack of  rejuvenation o f  the thymus or cellular immune 
function in the mice g iven da ily injections o f  growth 
hormone for four weeks at the same dose as the t imed 
rel ease pel lets . Furthermore , our results would seem to  
indicate that the rej uvenation o f  the senescent cellular 
immune response i s  not achieved as quickly as the 
rej uvenat ion of the thymus gland . The thymus rega i ned much 
of its normal young morphology a fter 8 weeks of growth 
hormone treatment but cel lular immune funct ion did not 
recover as quickly . Thi s  can be explained in either o f  two 
ways . First , it may be due to the t ime lag in the seed i ng 
o f  the peripheral lymphoid organs with newly matured and 
normal functioning thymocyte s  from the rej uvenated thymu s . 
Alternatively , it may be that the thymus factors 
respons ible for ma intaining the vigor of the cel lular 
immune response have not been present for a long enough 
period of time to restore peripheral lymphocytes to norma l  
funct ioning leve l s . The fact that previous studies have 
demonstrated the benef its o f  exogenous thymus factors to 
the senescent immune respons e  ( Cowan et al . ,  19 8 1 ; Fras c a  
et a l . ,  19 8 2 ; Frasca e t  a l . ,  1 9 8 7 ; Erschler , 1 9 8 9 ) woul d  
favor the latter explanation . However ,  a comb inat ion o f  
both newly derived lymphocyte s  and thymus factors may b e  
the mechanism by which the senescent cel lular immune 
response is restored . 
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Our analys i s  o f  the results found i n  the Con A 
pro l i ferat ion assay indicate that the response has not been 
s ign i ficantly improved . The margina l ly elevated 
pro l i feration rate seen in the unstimul ated cultures may b e  
due to the recent seeding o f  the spleen b y  newly matured T 
cel l s  exported from the restored thymus . I t  is pos s ib l e  
that the prol i ferat ion response a t  6�g/ml o f  Con A i s  a n  
indication of a nascent improvement that i s  only ev ident i n  
marginal prol i feration states ; the h igh prol i ferat ion rate 
during more vigorous responses masks thi s  emerging trend . 
We are currently planning studies that would involve l onger 
treatment periods to determine i f  thi s  interpretati on i s  
correct . 
The I L-2  assay did not show a s ign i ficant increase in the 
I L- 2  production of the growth hormone treated mice . There 
were , however ,  indications that perhaps I L-2  production was 
beginn ing to improve . The DPM counts were higher for the 
growth hormone treated mice but the i ncrease was not 
stat ist ically s ign i ficant . For examp l e , in the cul tures 
which were stimulated with 6 J,£g/ml of Con A,  the " p "  values 
for the difference between control and treated mice were 
0 . 0 5 8  - 0 . 07 5 . These results l end further support , 
although far from conclus ive evidence , to our hypothes i s  
that the cel lular immune response i s  beginning t o  improve 
in the treated mice . 
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The cytotoxic ity assay gave n o  i ndication that there was an 
improvement in th is aspect o f  cel lular immunity . The 
results varied greatly in both the experimental and control 
popu l at i ons with no s ign i f icant d i fferences between them . 
Unl ike the assays o f  cel lular immune function discussed 
above , there was no indicat ion o f  a trend toward 
improvement in the growth hormone treated mice with thi s  
assay . 
The high inc idence of hepatocel lular adenoma in the growth 
hormone treated mice appears to be more than j ust a chance 
occurrence rel ated to the age of the mice . Previous 
reports on the incidence o f  hepatic tumors in CBA mice vary 
greatly but none are as high a s  6 7 % , a lthough the incidence 
i s  higher than in other stra ins . Phybus and Mi l l er ( 19 4 2 ) 
reported an incidence o f  4 0 . 7 % at an average age 2 8 . 6  
months in a population o f  2 8 5  mice . Blankton ( 19 7 8 ) 
reported an incidence of between 1 1 %  and 2 3 %  depending on 
the c l a s s i f ication of the tumor . Cohen et al e ( 19 8 4 ) found 
hepat ic tumors in 6 2 . 5 % of 2 4  month old CBA mice . However ,  
they only examined 8 mice . The sma l l  s i z e  of our study 
popu l ation precludes a definitive find ing given that the 
popu l at ion under study is  known to have a high tumor 
inc idence . However ,  given the absence o f  tumors in pl acebo 
treated mice , these results do indicate that a correlati on 
between growth hormone and hepatic tumors is l ikely . We 
deem it imperat ive that investigators be aware of pos s ib l e  
s ide e f fects o f  any immunotherapy used in order t o  properly 
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interpret the results o f  in vivo studies and have included 
thes e  observations for that reason . 
The mechanism o f  act i on for growth hormone on the thymus i s  
unde f ined and the present study does not prov ide add i t i ona l 
in format ion in thi s  regard . I t  does seem clear that neuro­
endocrine factors have a pronounced e ffect on the thymus 
and immune funct ion ( Fabris  and Mochchegiani , 1 9 8 5 ; Berc z i 
1 9 8 6 ; Go ff  et al . ,  1 9 8 7 ) . In addition to the anteri o r  
p itu itary factors discussed above , thyroxine h a s  b e e n  shown 
to have pro found e f fects on the thymus and immune funct ion 
( Pierpaol i et al . ,  1 9 7 0 ; S chieff  et al . ,  1 9 7 7 ; Savino et 
al . ,  1 9 8 4 ) . Thyroxine i s  also  known to a ffect both growth 
hormone and prolactin product ion ( Peake et al . ,  1 9 7 3 ; 
Mart ial et al . ,  1 9 7 7 ) . How the interact ions o f  the s e  
various endocrine factors a f fect immune funct ion in both 
normal as wel l  as aberrant phys iological states we have 
only begun to understand . The fact that the thymus appears 
to  be funct ional ly intertwined with these endocrine o rgans 
may ind icate that a more thorough understanding of the 
thymus enta i l s  thinking of it as a member of that system . 
CHAPTER THREE 
The E f fects o f  PSR on the Senescent Immune System 
I nvolut ion o f  the thymus with age and the subsequent 
suppress ion of immune function are wel l  documented ( Boyd , 
1 9 3 2 ; Bach et al . ,  1 9 7 5a , b ;  H irokawa and Makinodan , 1 9 7 5 ; 
Wal ford , 19 8 0 ; Kru i sbeek , 1 9 8 1 ; Cowan et a l . ,  1 9 8 1 ; 
Weks l er , 1 9 8 2 , 1 9 8 3 ; steinman et a l . ,  1 9 8 5 ; Kra ft et a l . ,  
1 9 8 8 ) . However ,  the suppress ion o f  immune function in 
senescent anima l s  i s  not absolute and exh ibits at l east 
some revers ib i l i ty ( Gerbase-DeLima , 1 9 7 5 ; Cowan et a l . ,  
1 9 8 1 ; Frasca et a l . ,  1 9 8 2 ; Bruley-Rosset et al . ,  1 9 8 6 ) . 
Experimental attempts at immunol ogical restorat ion o f  
immunosenescent anima l s  general ly fal l  i nto one o f  three 
categories : 1 .  Attempts to replace phys iologica l l y  act ive 
factors that are l ost or diminished with age ( Weksler et 
al . , 19 7 8 ; Frasca et al . ,  1 9 8 6 ) ; 2 .  Pha rmaco l ogical 
t reatments ( Kwong et al . , 1 9 8 3 ; Bruley-Rosset et a l . ,  
1 9 7 5 ) ; and 3 .  Nutritional manipu l ations ( Fabr i s  et a l . ,  
1 9 8 6 ) . Limited success has been obta ined with each o f  
these forms of intervention . stil l ,  no c l inica l ly 
appl icable treatment has been found and the mechan i sms o f  
immunosenescence and restoration rema in poorly understood . 
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In a l l  three approaches to rej uvenat ion o f  the senescent 
immune response , sUbstances that act as immunomodul ators or 
biological response mod i fiers have been empl oyed ( Kwong et 
al . ,  1 9 8 3 ; Goodman and Weigl e , 1 9 8 5 ; Bru l ey-Rosset et 
al . ,  1 9 8 6 ; Cowan et al . ,  19 8 1 ; Frasca et a l . ,  1 9 8 6 ; 
Frasca et al . ,  1 9 8 7 ; Ershler et al . ,  1 9 8 9 ) . Many 
invest igators studying immunosuppressed states have 
attempted to restore normal immune function armed with 
pharmacological agents which are putative 
immunopotentiators . Examples o f  this are the work by 
Wybran ( 19 8 0 )  and Friedman et a l e ( 19 8 0 )  whi ch showed that 
isoprinos ine was an e ffective immunostimulator in canc e r  
pat ients . Tsang and Fudenberg ( 19 8 2 ) also found thi s  
compound t o  b e  a n  e ffective immunostimulator in a n  anima l 
model o f  human osteosarcoma . Based upon these 
observations , Tsang et al e ( 19 8 3 )  examined the e f fects o f  
isoprinos ine on the immunodeficiency o f  senescence . They 
found that isoprinos ine was abl e  to boost the cel lular 
immune response in aged hamsters . 
PSK i s  a fungal extract commonly used as part o f  cancer 
therapies in Japan , where it i s  widely regarded as  a n  
effect ive immunopotentiator in both laboratory anima l s  and 
human subj ects ( review : Tsukagoshi et al . ,  1 9 8 4 ) . PSK 
( Krestin ) , a prote in bound polysaccharide , i s  an  extract 
from the cultured mycel ia of the fungus Coriolus vers icolor 
o f  the Bas idiomycetes family . The phys iochemical 
properties of PSK are the fol l owing : an average molecu l a r  
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we ight o f  9 4 , 0 0 0 ; the protein portion i s  composed 
primarily o f  acidic and neutral amino acids with a sma l l  
amount o f  bas ic amino ac ids ; the maj or monosaccharide i s  
glucose ; the glycos ide port ion is  composed o f  B 1 - 4  
glucan l inkages branched a t  the C3 and C6  pos it ions in a 
rat io o f  one per several res idual groups o f  1 - 4  bonds 
( Tsukagoshi et al . ,  1 9 8 4 ) . PSK is  an odorl ess , taste l e s s , 
water-soluble , brown powder .  PSK activity i n  v ivo has been 
achieved with oral , intravenous , and intraperitoneal 
admini stration . Its  speci fic mechanism o f  act ion rema ins 
unclear , but PSK ' s activity as a biological response 
mod i f ier has been the obj ect o f  numerous stUdies . 
PSK has been shown to augment the immune response aga inst 
a l l ogene ic ant igens and increase the survival t ime of tumor 
bearing mice ( Ehrke et al . ,  198 3 ) . Cel l  medi ated 
cytotoxic ity is also  increased by PSK treatment in mice 
( Tan iguchi et a l . ,  1 9 8 5 ) . O f  part icular interest i s  the 
reported abi l ity of PSK to restore the involuted thymuses 
of tumor-bearing mice to the normal state (Mi zush ima et 
al . , 1 9 8 2 ; Tsuru et a l . ,  1 9 8 3 ; Oguchi et a l . ,  1 9 8 7 ) . The 
suppress ion of immune function in neoplast i c  di sease states 
is  wel l  known ( review : Kamo and Friedman , 1 9 7 7 ) , wh i l e  the 
combination of suppressed immune response and thymic 
involut ion is  reminiscent o f  the senescent state o f  the 
immune system . Even more noteworthy i s  the reported 
abil ity of PSK to restore the immune funct ion of tumor-
bearing aged mice to pre-tumor l evel s  ( Matsunaga et a l . ,  
1 9 8 7 ) . 
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The etiology of the tumor induced immunosuppress ion and 
thymic involut ion is  not entirely understood but its 
s imilarity to the senescent state i s  cons iderable . G iven 
these s imilarities and the reported success o f  PSK in 
revers ing these del eterious processes , we were encouraged 
to  investigate the pos s ib i l ity o f  PSK rej uvenation o f  the 
senescent immune system . Previous work has shown that a t  
l east one pharmacological agent , isoprinos ine , is  capabl e  
o f  acting a s  an immunopotent iator o f  both tumor suppres s ed 
immune systems and senescence induced immunosuppre s s i on . 
The results o f  previous investigations using PSK indicate 
that it may have s imilar therapeutic value . 
Materi als and Methods 
Animal s 
CBA male mice 18 months o f  age were obta ined from Charles 
River Laboratories ( Kingston , NY ) through the National 
Institute on Aging . Mice were housed 3 per cage . The 
cages were kept in laminar flow hoods on a 12  hour 
l ight/dark cycle . Mice were provided with water and 
autoc l aved Purina mouse chow ad l ibitum . 
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PBK 
The PSK used in thi s  work was the generous g i ft of Dr . J ane 
Ehrke and Kureha Chemical Co . Ltd . ( Japan ) . The brown 
p owder was dissolved in norma l sal ine at a concentration o f  
1 7 5  mg/ml and 1 . 0 0 ml was administered three t imes a week 
for 4 weeks via intra-per itoneal inj ections . 
Antigen Priming 
P8 1 5  tumor cel ls  were i rradiated with 1 0 0 0  rads and an 
i noculum of 1x107 was administered in 0 . 5  ml o f  PBS at the 
end of the PSK treatment period . The mice were sacri f i ced 
by cerv ical dislocation 1 0  days a fter P8 1 5  priming . 
Hi s tology 
Thymus glands were removed and fixed in neutral buf fe red 
forma l in after which they were dehydrated in graded 
a l cohols ,  infi ltrated and embedded in JB-4 embedding 
p l astic . Sections 3 - 5�m thick were cut and sta ined with 
hematoxyl in and eos in for l ight microscopy . 
cytotoxicity Assay 
Spl eens from experimental and control animals  were removed 
steri l ely , erythrocytes were lysed , and cel l suspens ions 
prepared and washed . The cel l s  were cultured at a 
concentrat ion of 5x1 06 cel l s/we l l  in a 2 4  wel l  flat 
bottomed plate ( Costar , Cambridge , MA ) with 0 ,  2 ,  o r  6 �m 
of Con A /ml per group of cel l s  and 3 wel l s  per dose in 1 
ml o f  media ( RPMI + 1 0 %  serum , lxPen/Strep , sod ium 
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pyruvate , nonessential  amino ac ids , and 2 -mercaptoethano l ) . 
Pl ates were incubated for 4 0  hours at 3 7 ° C  in 5 %  CO2 •  
Ce l l s  were harvested by v igorous p ipett ing . Fol l owing 
centri fugation , the supernatants were col l ected and fro z en 
for l ater use in the I L- 2  assay . These cultured e f fector 
cel l s  were plated to yield e f fector-target cel l  rati o s  o f  
5 0 : 1 , 2 5 : 1 , 1 2 . 5 : 1 , 6 . 2 5 : 1 , and 3 . 12 5 : 1  i n  a 9 6  wel l  f l at 
bottomed plate ( Costar) . F i fty � l  o f  PHA ( 1 0 0�g/ml ) was 
added to the cul tures j ust prior to adding the 51cr 
l abe l l ed P8 15  target cel l s  ( 5X 1 05 cel l s/wel l ) . The p l ates 
were centri fuged brie fly before being incubated at 3 7 ° C  in 
5% CO2 for 5 hours . The supernatants were harvested with a 
Skatron Harvesting Press and counted in an LKB automatic 
gamma counter . 
Con A stimul ation 
The media used for the assay was the same as above . F inal  
doses o f  Con A were 0 ,  0 . 6 7 ,  2 ,  6 ,  1 8 , and 5 4  �g/ml . Each 
dose was pl ated in tripl icate in a 9 6  wel l  p l ate . Spleen 
cel l s  were plated at 1 . 2 5X 1 06/wel l .  The pl ates were 
cultured for three days at 3 7 ° C  in 5 %  CO2 , a fter whi ch they 
were pulsed with 3H thymidine ( l�Ci/wel l ) , incubated for 7 
hours , and harvested with a Skatron Cel l  Harvester onto 
f ilter paper . The cel l s  were counted in a Beckman LS 7 5 0 0  
l iqu id scint i l lat ion counter . 
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I L- 2  As say 
Supernatants from the spleen cel l  cultures used in the 
cytotoxic ity assay were evaluated for the presence of I L- 2  
a s  f o l l ows . Several two-fold d i lutions o f  the supernatant 
and a standard I L- 2  solut ion were a l i quoted in trip l icate 
in 96  wel l U-bottom plates ( 0 . 1 ml/wel l )  and 1 04 I L- 2  
dependent CTLL cel l s  were added per wel l . The p l ates were 
cul tured for 24 hours at 3 7 ° C  in 5% CO2 , then plates were 
pul sed with 3H thymidine and returned to the incubator f o r  
5 hours . The cel l s  were harvested onto f i lter paper w i th a 
Skatron Cel l  Harvester and counted in a Beckman LS 7 5 0 0  
l iquid scint i l l ation counter . 
RE SOLTS 
A fter four weeks o f  treatment with PSK the mass of the 
thymus was not increased in the 18 month old mice . The 
mean values for thymus mass were 7 . 3 8 mg for the PSK 
treated animals and 9 . 6 5 mg for the sal ine treated 
control s .  These values were not s ign i ficantly d i f ferent ( p  
= 0 . 19 ) . There was however an unexpected increase i n  the 
mass of the spleen in the PSK treated mice compared to both 
the old sal ine treated control s  and the young control s  
( Tabl e  3 . 1 ) . This increase i n  splenic mas s  was not due to 
an increase in white blood cel l s  s ince cel l  counts 
fol l owing lysis of erythroid cel l s  did not revea l  a 
s ign i f i cant dif ference between the PSK and control mice 
( Tabl e  3 . 2 ) . 
TABLE 3 . 1  SPLEEN MAS S  
Anima l  Mas s  
PSK 1 7 8  mg 
Sa l ine 1 0 8  mg 
Young 7 3  mg 
Splenic mass  mean va lues for aged PSK or s a l ine 
treated and young control mice . PSK treated 
mice had s ign i f i cantly enl arged spleens when 
compared to sal ine treated aged ( p=0 . 0 0 3 ) and 
untreated young mice ( p=0 . 0 0 5 ) . 
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Table 3 . 2  Non-erythro id Spleen Cel l s  
X ( xl 03 ) (j ( xl 03 ) 
PSK 3 . 3 3 2 . 4 1 
SALINE 2 . 54 1 . 5 2 
YOUNG 0 . 7 5 0 . 2 3 
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The thymuses o f  the PSK treated mice were not restored t o  
normal youthful morphology when examined h istologica l ly .  
Both the control and PSK treated mice ' s  thymuses were 
s ign i f icantly involuted as seen in Figure 3 . 1 . Only a f ew 
o f  the anima l s  exhib ited any dist inction between cort ic a l  
and medu l lary regions and these were equal ly distributed 
between experimental and control groups . The most common 
appearance of the thymus was an irregularly shaped mas s  o f  
t i s sue evenly populated with lymphocytes and conta ining 
varying amounts o f  white and brown fat ( Figure 3 . 1 ) . Many 
o f  the ep ithel ial -l ike cel l s  had a vacuolated appearing 
cytoplasm .  Hassal ' s  corpuscles were not seen . Al l o f  
the above histological f i ndings are cons istent with normal 
age-related thymus involut ion . 
The Con A response was h ighly variable as seen in Figure 
3 . 2 .  The means o f  the raw data did not indicate any c l ea r  
pattern o f  improvement i n  Con A response in the PSK treated 
anima l s . statistical analys i s , us ing a repeated measures 
analys i s  of variance ( SAS , 1 9 8 5 ) , confirmed that there were 
no s ign i ficant di fferences in Con A response between the 
experimental and control groups at any of the leve l s  
examined . 
The cytotoxic T lymphocyte activity , as measured by the 
abi l ity of cultured splenocytes to lyse SlCr label l ed P8 1 S  
cel l s , was not improved b y  PSK treatment . Prel iminary 
results ind icated that the PSK treated mice might have 
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F i gure 3 . 1 a :  Thymus o f  an eighteen month old  mouse treated 
with PSK every other day for one month . Note the lack of a 
d i stinct cortex and medu l l a . In thi s  s ection both wh i t e  ( WA )  
and brown ( BA )  ad ipose t i s sue are seen . ( 6 . 3 X ) . 
Figure 3 . 1 b :  Thymus o f  an e i ghteen month o l d  mouse given 
s a l ine injections for one month . Observe that the per i phera l 
area which i s  dark s t a i n i ng with l ymphocytes i n  a norma l young 
thymus is n e a r l y  devoid of l ymphocytes at s evera l points 
( arrows ) in thi s specimen . ( 6 . 3 X ) . 
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higher ki l l ing than the control treated mice . The resul ts , 
however , var ied between experiments . Pool ed data va lues 
were higher in PSK treated mice than control mice at high 
e f fector : target ratios , equal at midd l e  rat ios , and l e s s  
than control s  a t  l ow ratios . Due to the high degree o f  
variab i l ity , none o f  these d i fferences was stat ist ica l ly 
s ign i f icant . 
Product ion o f  IL-2 by cultured spl een cel l s , stimul ated 
with Con A, was assayed by the ab i l ity of col lected 
supernatants to promote the growth of the I L- 2  dependent 
cel l l ine CTLL . The production of I L- 2  was not increased by 
the PSK treatment of the aged mice . There was no 
s ign i ficant d i fference between the sal i ne treated and the 
PSK treated mice . 
DISCUSS ION 
As was di scussed in the introduction , the e f fectivenes s  o f  
PSK i n  restoring both thymus structure and cel lular immune 
funct ion in the tumor-suppressed immune response and the 
s imilarity of thi s  state to the senescent state indicated a 
possible role for PSK as  an immunopotent iator in aged mice . 
In  thi s  study , treatment of aged mice with PSK did not 
induce thymic rej uvenat ion as has been reported in prev i ous 
studies of PSK treatment of tumor-bearing an imal s  ( Tsuru et 
a l . ,  1 9 8 3 ; Oguchi et al . ,  1 9 8 7 ) . The thymuses o f  the PSK 
treated mice were indistingu i shable from the thymuses o f  
the control mice i n  terms o f  mas s  and h i stologica l 
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appearance . Furthermore , cellular immune funct ion in the 
PSK treated aged mice was not improved over that of the 
aged controls .  The studies o f  PSK in tumor-bearing anima l s  
c ited above had also reported a restoration o f  suppres s ed 
immune response . Whatever the mechanism o f  tumor- induced 
thymic involution it appears to be d i f ferent from the 
senescence- induced thymi c  involut ion . Recent work has 
shown that it is  pos s ib l e  to rej uvenate the senescent 
thymus in experimental anima l s  with growth hormone 
( M i zushima et al . ,  1 9 8 2 ; Gof f  et a l . ,  19 8 7 ; Kel l ey et 
a l . , 1 9 8 6 ; Roth et al . ,  1 9 8 8 ; also see Chapter 2 ) , but PSK 
appears to lack such restorative properties . 
There are several plaus ibl e  explanations o f  the fa i lure o f  
the PSK therapy to augment the senescent immune response .  
The dose and length o f  the treatment period were based o n  
the success ful methods o f  researchers us ing PSK to bol ster 
the suppressed immune response o f  tumor-bearing anima l s  and 
human cancer pat ients . While thes e  protoco l s  were 
appropriate for the first phase o f  thi s  study , it i s  
poss ible that a longer treatment period may be necessary t o  
counteract the accumulated damages o f  aging . I f  th i s  l ine 
o f  i nvestigation is pursued in  future studies , a range o f  
doses and treatment periods wi l l  be examined . Even i f  the 
fa i lure of the current study to show improvement were due 
to insufficient PSK treatment , one would expect to see at 
least a trend toward improved immune funct ion or a s l ight 
improvement in thymus morphology if that organ were 
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beginning to rej uvenate . In terms o f  cel l u l a r  immune 
function , it may be a matter of timing and antigen 
presentation . PSK has been shown to increase or decrease 
cel lular immune funct ion depending on when it is  g iven 
rel at ive to antigen presentation ( Taniguchi et al . ,  1 9 8 5 ) . 
I t  has been postulated to increase suppre s s or T cel l  
act ivity under one set o f  conditions and t o  augment 
cytotoxic T cel l activity under other cond i t i ons . The 
protocol used in the current study did not invest igate the 
pos s ib i l ity of such paradoxical e ffects o f  PSK on senescent 
immune funct ion . 
One of the most striking results o f  the PSK therapy was the 
splenomegaly . The dramat ic hypertrophy o f  the spleen was 
not expected s ince it had been previous ly reported that PS K 
had no e f fect on the spleen ( Tsuru et a l . ,  1 9 8 3 ) . Thi s  
increase i n  splenocytes suggested to u s  that perhaps the 
increased anti-tumor activity reported in previous stud ies 
was due to an  increase in the number o f  lymphocytes in the 
peripheral lymphoid organs . Our examinati on o f  the total 
leukocyte count in the spleens o f  PSK treated mice revealed 
that the increase in the number o f  l eukocyte s  was 
ins ign i ficant ( Table 3 . 2 ) and there fore thi s  could not be 
the mechani sm by which the previous resu l t s  i n  tumor­
bearing mice were obtained . 
Kikuchi et al e ( 19 8 8 ) demonstrated an improvement in  I L- 2  
product ion i n  post-chemotherapy cancer pat ients g iven da ily 
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doses o f  PSK . The improvement i n  thi s  measure o f  ce l lu l a r  
immune functi on in non-tumor bearing subj ects ind icates a 
poss ib l e  therapeut ic role that does not involve the 
inhibit ion of tumor derived factors . S everal studies , 
however , have presented strong evidence for a mechani sm o f  
act i on for PSK that involves the inhibiti on or blocking o f  
tumor-produced immunosuppress ive factors to restore the 
suppressed immune function (Matsunaga et al . ,  19 8 5 ; 
Matsunaga et al . ,  19 8 6 ; Oguchi et a l . ,  1 9 8 7 ) . The resu l t s  
o f  thi s  study d o  not indicate any pos itive therapeut i c  
e f fect o f  PS K o n  the depressed I L- 2  product ion , l ect i n  
med iated pro l i ferat ion , or CTL activity in senescent mice . 
The absence o f  pos itive results in the current study i s  
cons istent with the hypothesis  that PSK acts by blocking 
the immunosuppress ive e ffects o f  tumor produced factors 
rather than acting directly on lymphocytes . 
The only other publ ished study using PSK in older anima l s  
( Matsunaga e t  al . ,  1 9 8 7 ) supports our f inding that PSK i s  
incapable o f  boosting the senescent immune response .  They 
demonstrated that PSK was e ffective in improving the tumor 
res i stance and the cel lular immune function - PHA response 
and foot pad reaction to sheep e rythrocytes - in tumor­
bearing aged ( 6 0 week old ) mice . However , the antitumor 
effects o f  PSK were not as great in the older mice as  they 
were in young ( 3 0  week old ) mice . Further ,  the 
improvement in the PSK treated aged tumor-bearing mice was 
on l y  to the level o f  non-tumor-bearing aged mice ; i . e . the 
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PSK treatment overcame the tumor induced immunosuppres s ion 
but did not improve the senescent response . These resu l t s  
re fl ect a basel ine functi onal l evel ( senescent immune 
functi on )  which can be further depressed by tumor burden 
but not augmented by PSK .  
I t  i s  poss ible that PSK therapy must start at a younge r  age 
in order to restore the senescent immune function i . e .  that 
a window of opportunity exists at a younger age for PSK 
improvement o f  senescent immune function ; but we think it 
unl ikely . Matsunaga et a l . ( 19 8 7 ) performed thei r  work on 
mice which were s ign i f icantly younger than the mice i n  the 
current study . The equivalent age for a CBA mouse , i n  terms 
of survivorship , would only be 5 months old . However , the 
mice were shown to be in an immunosenescent state and 
there fore were old in terms of biological functi on even i f  
they did not meet van Zweiten et al . ' s  ( 19 8 1 )  crite r i on for 
aged animals  ( i . e . past the 50% survival age on the 
stra in ' s  survival curve ) . 
It  appears that there i s  no prophylactic role for PSK ,  only 
a poss ible therapeuti c  rol e  in treating neopl asti c  
d iseases . stil l , i f  PSK i s  e ffective in this  manner for 
elderly pat ients it could prove to be an extremel y  
important new a l ly o f  the oncol ogist treating thi s  patient 
population . 
GENERAL DISCUSSION 
Thi s  work has i nvestigated three pos s ible  means o f  
improving the senescent immune system . The first chapter 
recounted e f fort s  to both improve the status o f  immune 
system cel l s  ( bone marrow prothymocytes ) and add to  our 
understanding of the interactions of the thymus and bone 
marrow stem cel l s . The second chapter chronicled our use 
o f  a murine model to investigate the reported rej uvenat i ng 
e ffects o f  growth hormone on the senescent thymus and 
immune system . I n  the third chapter ,  an invest igat ion o f  
the poss ible benef its o f  the fungal extract PSK o n  the aged 
thymus and cel lular immune functi on was reported . Thes e  
three invest igat ions met with varying degrees of success 
but both individual ly and col l ectively they represent an 
addition to our knowl edge o f  the immunosenescent state . 
The invest igation o f  the effects o f  thymus supernatant on 
bone marrow cel l s  from senescent mice revealed that thymus 
products may be respons ible for the ma intenance o f  norma l 
prothymocytes in the bone marrow . As deta i l ed in that 
chapter , others have speculated that the thymus may act on 
the bone marrow cel l s  but there has been l ittle 
invest igat ion o f  the hypothe s i s . In the context o f  
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prev ious work in thi s  laboratory and others , these resu l t s  
eluc idate several points . F i rst , bone marrow cel l s  from 
aged mice have a decreased abi l ity to migrate to the 
thymu s . Second , the s im i l a ri ty o f  the results found i n  the 
in v itro assay of  bone marrow chemotaxis and the bone 
marrow chimeras supports the val idity of these assays a s  
mea sures o f  the abil ity o f  bone marrow cel l s  t o  repopul at e  
the thymus . Third , the improvement in  the thymus d i rected 
chemotaxis  with thymus supernatant treatment , both in  v itro 
and in vivo , indicates that there i s  s ome factor in the 
supernatant which activates or augments the thymus homing 
popu l at ion o f  bone marrow cel l s  in senescent mice . 
The work presented in the f i rst chapte r  l eaves several 
unres olved questions . I t  does not reveal what in thymus 
supernatant i s  respons ible for its ab i l ity to improve the 
thymus homing abil ity o f  bone marrow cel l s . An unexamined 
poss ib i l ity i s  that the respons ible factor is not uni que t o  
the thymus . We are currently maki ng supernatants f rom 
other organs to test thi s  hypothes i s . Also unres olved i s  
what role , i f  any , decreased bone marrow cel l funct i on 
p l ays in the cellular immune dys function o f  the elderly . 
Bas ed on our current knowledge of  immunosenescence , we do 
not bel i eve that this is a maj or factor . It  i s  poss ib l e  
that w e  under estimate the need for newly derived T c el l s . 
I f  newly derived T cel l s  are needed to ma inta in normal 
immune function , this would greatly e l evate the importance 
o f  a deficit in T cel l precursors . 
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The work presented in the second chapter represents an 
attempt to repl icate the rej uvenat ion of thymus and 
cel lular immune function previous ly reported in other 
spec ies . As such , it  does not represent a novel approach 
to the problem o f  boosting the senescent immune respon s e . 
I t  does represent , however , an attempt to evaluate thi s  
putat ive therapeutic method i n  the context o f  a wel l  
studied model , the mouse . The value o f  the results i s  in  
the foundation they l ay for further studies to eluc idate 
the mechanism of action o f  anterior p itu itary hormones on 
the immune system in general and senescent immune funct ion 
in  particular . Having demonstrated the poss ib i l ity o f  
thymic and cel lular immune function rej uvenation i n  the 
mouse , an animal model that has been extens ively stud i ed , 
the appl icat ions and l imitati ons o f  growth hormone the rapy 
can be evaluated using previously val idated too l s  and 
techniques . For example , it i s  pos s ib l e  to evaluate 
poss ible deleterious s ide effects by comparing observed 
anoma l ies to previously documented pathol ogies , as  was done 
here . The mouse is  an attract ive model for such work 
because its immune system has been wel l  character i z ed and 
can be readi ly compared to the human immune system . 
The th ird chapter deta ils  an attempt to use an unorthodox , 
but reportedly e ffective , immunopotent iator o f  tumor­
suppressed immune function to boost the senescent immune 
response . The attempt failed . The s imi l arities between 
tumor induced immune suppress ion and immunosenescence 
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appear t o  b e  analogous end products o f  very d i f ferent 
b i o l ogical processes . The results o f  thi s  study do not 
preclude a poss ible role for natural ly derived b i o l og i c a l  
response mod i fiers in therap ies a imed at mit igating the 
decl ine o f  immune function with age . They do not , however ,  
g ive any indication that PSK i s  a promis ing candidate for 
such a therapy . 
I n  examining the immunosenescent state in humans one cannot 
help but be struck by the quandary that modern b i omedical  
advances have created . The fai lure o f  the human body to  
ma inta in immunocompetence into the l ater years o f  l i fe is  
the catch-2 2  o f  the l i fespan extens ion achieved over the 
past century . We have effectivel y  outl ived our immune 
system ' s  funct ional l i fespan . The resul t  is both a del ayed 
mortal ity and a greatly increased morb id ity . Modern 
med i c ine has attempted to contradict evolut ion and the 
price which nature has extracted is cal l ed 
immunosenescence . 
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